Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-107 ABCA6 1.31 0 -2.84 1.0E-5 miRanda -0.5 0.00122 NA
2 hsa-miR-129-5p ABCA6 -0.52 0.22258 -2.84 1.0E-5 miRanda -0.16 0.02669 NA
3 hsa-miR-338-3p ABCA6 0.45 0.14458 -2.84 1.0E-5 miRanda -0.2 0.04168 NA
4 hsa-miR-342-3p ABCA6 1.49 0 -2.84 1.0E-5 miRanda -0.27 0.01159 NA
5 hsa-miR-362-3p ABCA6 2.08 0 -2.84 1.0E-5 miRanda -0.27 0.00894 NA
6 hsa-miR-421 ABCA6 1.18 1.0E-5 -2.84 1.0E-5 miRanda -0.23 0.04461 NA
7 hsa-miR-590-3p ABCA6 2.59 0 -2.84 1.0E-5 miRanda -0.47 2.0E-5 NA
8 hsa-miR-590-5p ABCA6 3.18 0 -2.84 1.0E-5 miRanda -0.39 8.0E-5 NA
9 hsa-miR-192-5p ABCA8 2.69 0 -5.33 0 miRNAWalker2 validate -0.52 0 NA
10 hsa-miR-320b ABCA8 1.56 0 -5.33 0 miRanda -0.59 0 NA
11 hsa-miR-361-5p ABCA8 0.97 0 -5.33 0 miRanda -0.7 0.00034 NA
12 hsa-miR-375 ABCA8 1.14 0.05123 -5.33 0 miRanda -0.15 0.0062 NA
13 hsa-miR-590-3p ABCA8 2.59 0 -5.33 0 miRanda -0.89 0 NA
14 hsa-miR-155-5p ABCC4 1.2 0.00086 -1.54 1.0E-5 miRNAWalker2 validate -0.18 0.0001 NA
15 hsa-miR-21-5p ABCD3 2.74 0 0.14 0.52609 miRNAWalker2 validate -0.18 0.00032 NA
16 hsa-miR-484 ABHD2 1.82 0 -0.37 0.12248 miRNAWalker2 validate -0.12 0.01844 NA
17 hsa-miR-484 ABL1 1.82 0 -1.32 0 miRNAWalker2 validate -0.28 0 NA
18 hsa-miR-107 ACACB 1.31 0 -2.93 0 miRanda -0.55 0 NA
19 hsa-miR-148b-3p ACACB 1.98 0 -2.93 0 miRNAWalker2 validate -0.68 0 NA
20 hsa-miR-324-5p ACACB 2.96 0 -2.93 0 miRanda -0.37 0 NA
21 hsa-miR-361-5p ACACB 0.97 0 -2.93 0 miRanda -0.48 0 NA
22 hsa-miR-455-5p ACACB 2.26 0 -2.93 0 miRanda -0.4 0 NA
23 hsa-miR-542-3p ACACB 1.19 0 -2.93 0 miRanda -0.26 0.00023 NA
24 hsa-miR-28-5p ACAT1 0.23 0.07429 -1.05 0 miRanda -0.31 0.00011 NA
25 hsa-miR-484 ACTA2 1.82 0 -3.5 0 miRNAWalker2 validate -0.91 0 NA
26 hsa-miR-484 ACTB 1.82 0 -0.54 0.00046 miRNAWalker2 validate -0.17 0 NA
27 hsa-miR-148a-3p ACVR1 1.27 0 -0.44 0.01143 miRNAWalker2 validate; miRTarBase -0.11 0.00035 NA
28 hsa-miR-28-5p ADA 0.23 0.07429 0.71 0.04475 miRanda -0.55 6.0E-5 NA
29 hsa-miR-155-5p ADAM10 1.2 0.00086 0.67 0.00766 miRNAWalker2 validate -0.11 0.00135 NA
30 hsa-miR-28-5p ADAMTSL1 0.23 0.07429 -2.52 0 miRanda -0.39 0.03175 NA
31 hsa-miR-148a-3p ADARB1 1.27 0 -1.93 0 miRNAWalker2 validate -0.31 0 NA
32 hsa-miR-375 ADARB1 1.14 0.05123 -1.93 0 miRanda -0.1 5.0E-5 NA
33 hsa-miR-429 ADH1B 4.49 0 -7.89 0 miRanda -0.43 0 NA
34 hsa-miR-491-5p ADH1B 0.62 0.04183 -7.89 0 miRanda -0.48 0.00223 NA
35 hsa-miR-590-3p ADH1B 2.59 0 -7.89 0 miRanda -1.26 0 NA
36 hsa-miR-590-3p ADH1C 2.59 0 -3.38 7.0E-5 miRanda -0.46 0.00247 NA
37 hsa-miR-129-5p ADIPOQ -0.52 0.22258 -5.02 0 miRanda -0.21 0.02898 NA
38 hsa-miR-320a ADIPOQ 0.44 0.03902 -5.02 0 miRanda -0.92 0 NA
39 hsa-miR-320b ADIPOQ 1.56 0 -5.02 0 miRanda -1.2 0 NA
40 hsa-miR-326 ADIPOQ 0.72 0.06103 -5.02 0 miRanda -0.24 0.02296 NA
41 hsa-miR-330-5p ADIPOQ 1.15 0 -5.02 0 miRanda -0.72 4.0E-5 NA
42 hsa-miR-339-5p ADIPOQ 2.69 0 -5.02 0 miRanda -0.54 1.0E-5 NA
43 hsa-miR-429 ADIPOQ 4.49 0 -5.02 0 miRanda -0.66 0 NA
44 hsa-miR-590-3p ADIPOQ 2.59 0 -5.02 0 miRanda -1.12 0 NA
45 hsa-miR-21-5p ADNP 2.74 0 0.23 0.1236 miRNAWalker2 validate -0.1 0.00175 NA
46 hsa-miR-28-5p AFF4 0.23 0.07429 -0.82 0 miRanda -0.16 0.00747 NA
47 hsa-miR-155-5p AGL 1.2 0.00086 -0.67 6.0E-5 miRNAWalker2 validate -0.17 0 NA
48 hsa-miR-155-5p AGTR1 1.2 0.00086 -4.49 0 miRNAWalker2 validate; miRTarBase -0.18 0.02184 22525818 MicroRNA-155 miR-155 is one of the micro RNAs miRNA most consistently involved in neoplastic diseases and it is known to repress the angiotensin II type 1 receptor AGTR1; The aim of the present study was to evaluate the expressions of miR-155 and AGTR1 and to clarify the potential efficacy of anti-miR-155 alone and in combination with AGTR1 blocker losartan in endometrial cancers; Expressions of miR-155 and AGTR1 were evaluated using real-time PCR and immunohistochemistry; miR-155 was over-expressed and AGTR1 was underexpressed in endometrial carcinoma tissues; We checked that abolishing the function of miR-155 and AGTR1 by anti-miR-155 or losartan inhibited cell survival of endometrial carcinoma cells respectively and furthermore combined treatment showed synergistic effects; In this study we characterized the expressions of miR-155 and AGTR1 in endometrial tissues; The combined treatment with anti-miR-155 and losartan has a synergistic antiproliferative effect and an improved understanding is required to clarify whether miR-155 and AGTR1 can be used as a novel therapeutic target in endometrial cancer
49 hsa-miR-484 AHDC1 1.82 0 -0.69 6.0E-5 miRNAWalker2 validate -0.18 0 NA
50 hsa-miR-28-5p AHNAK 0.23 0.07429 -1.66 0 miRanda -0.44 3.0E-5 NA
51 hsa-miR-183-5p AKAP12 4.2 0 -2.95 0 miRNAWalker2 validate; miRTarBase -0.33 0 NA
52 hsa-miR-28-5p AKAP13 0.23 0.07429 -1.15 0 miRanda -0.21 0.00067 NA
53 hsa-miR-484 AKAP13 1.82 0 -1.15 0 miRNAWalker2 validate -0.34 0 NA
54 hsa-miR-28-5p AKAP2 0.23 0.07429 -2.51 8.0E-5 miRanda -0.64 0.01054 NA
55 hsa-miR-21-5p AKAP9 2.74 0 -0.05 0.758 miRNAWalker2 validate -0.14 9.0E-5 NA
56 hsa-miR-28-5p AKIRIN1 0.23 0.07429 -0.65 1.0E-5 miRanda -0.16 0.00394 NA
57 hsa-miR-155-5p AKR1C3 1.2 0.00086 -0.32 0.59634 miRNAWalker2 validate -0.28 0.0004 NA
58 hsa-miR-15a-5p AKT3 2.35 0 -1.94 0 miRNAWalker2 validate; miRTarBase -0.65 0 NA
59 hsa-miR-142-3p ALDH1A2 2.75 0 -1.89 0.0017 miRanda -0.4 0 NA
60 hsa-miR-155-5p ALDH1A2 1.2 0.00086 -1.89 0.0017 miRNAWalker2 validate -0.42 0 NA
61 hsa-miR-193b-3p ALDH1A2 2.26 0 -1.89 0.0017 miRNAWalker2 validate -0.43 0 NA
62 hsa-miR-455-5p ALDH1A2 2.26 0 -1.89 0.0017 miRanda -0.47 0 NA
63 hsa-miR-28-5p ALDH3A2 0.23 0.07429 -0.63 0.00987 miRanda -0.28 0.00293 NA
64 hsa-miR-155-5p ALDH5A1 1.2 0.00086 0.21 0.50454 miRNAWalker2 validate -0.19 1.0E-5 NA
65 hsa-miR-28-5p ALG9 0.23 0.07429 -0.29 0.00937 miRanda -0.14 0.00107 NA
66 hsa-miR-21-5p ALMS1 2.74 0 -0.12 0.43567 miRNAWalker2 validate -0.14 3.0E-5 NA
67 hsa-miR-146b-5p AMIGO2 1.76 0 0.86 0.01664 miRanda -0.21 4.0E-5 NA
68 hsa-miR-155-5p AMIGO2 1.2 0.00086 0.86 0.01664 miRNAWalker2 validate -0.2 3.0E-5 NA
69 hsa-miR-484 AMOTL1 1.82 0 -1.62 0 miRNAWalker2 validate -0.49 0 NA
70 hsa-miR-28-5p ANGEL1 0.23 0.07429 0.18 0.17338 miRanda -0.2 7.0E-5 NA
71 hsa-miR-28-5p ANKRD37 0.23 0.07429 -1 0.00037 miRanda -0.22 0.04189 NA
72 hsa-miR-21-5p ANKRD46 2.74 0 -0 0.99261 miRNAWalker2 validate; miRTarBase -0.26 0 21219636 Knockdown of miR-21 significantly increased the expression of ANKRD46 at both mRNA and protein levels; ANKRD46 is newly identified as a direct target of miR-21 in BC
73 hsa-miR-28-5p ANXA1 0.23 0.07429 -1.02 0.01757 miRanda -0.88 0 NA
74 hsa-miR-92b-3p AP1B1 1.2 0 0.51 0.00062 miRNAWalker2 validate -0.12 1.0E-5 NA
75 hsa-miR-28-5p AP2A2 0.23 0.07429 -0.29 0.01105 miRanda -0.21 0 NA
76 hsa-miR-28-5p AP3S1 0.23 0.07429 -0.06 0.68914 miRanda -0.27 0 NA
77 hsa-miR-28-5p AP4E1 0.23 0.07429 -0.37 0.00476 miRanda -0.21 3.0E-5 NA
78 hsa-miR-15b-5p AP4S1 1.57 0 -0.6 0.00055 miRNAWalker2 validate -0.13 0.00064 NA
79 hsa-miR-148a-3p APC 1.27 0 -0.6 0.00012 miRNAWalker2 validate -0.12 2.0E-5 NA
80 hsa-miR-21-5p APC 2.74 0 -0.6 0.00012 miRNAWalker2 validate -0.21 0 23773491; 24832083 The prognostic significance of APC gene mutation and miR 21 expression in advanced stage colorectal cancer; The aim of this study was to analyse the association of APC gene mutation and miR-21 expression with clinical outcome in CRC patients; APC gene mutation and expression of APC and miR-21 were analysed by direct DNA sequencing and real-time reverse transcription polymerase chain reaction; APC gene expression was low in CRC and negatively correlated with miR-21 expression and gene mutation; In Taiwan downregulation of the APC gene in CRC correlated with gene mutation and miR-21 upregulation; APC mutation and miR-21 expression could be used to predict the clinical outcome of CRC especially in patients with advanced disease;MicroRNA 21 promotes tumour malignancy via increased nuclear translocation of β catenin and predicts poor outcome in APC mutated but not in APC wild type colorectal cancer; However in our preliminary data the prognostic value of miR-21 levels was observed only in adenomatous polyposis coli APC-mutated tumours not in APC-wild-type tumours; We enrolled 165 colorectal tumour to determine APC mutation miR-21 levels and nuclear β-catenin expression by direct sequencing real-time PCR and immunohistochemistry
81 hsa-miR-375 APOB 1.14 0.05123 -2.15 0.0006 miRanda -0.15 0.00392 NA
82 hsa-miR-142-3p APOD 2.75 0 -3.11 0 miRanda -0.3 0.0001 NA
83 hsa-miR-21-5p APOLD1 2.74 0 -2.62 0 miRNAWalker2 validate -0.53 0 NA
84 hsa-miR-92b-3p APOLD1 1.2 0 -2.62 0 miRNAWalker2 validate -0.14 0.01195 NA
85 hsa-miR-15a-5p APP 2.35 0 -0.4 0.04288 miRNAWalker2 validate -0.22 0 NA
86 hsa-miR-484 APP 1.82 0 -0.4 0.04288 miRNAWalker2 validate -0.19 0 NA
87 hsa-miR-21-5p APPL1 2.74 0 -0.26 0.06236 miRNAWalker2 validate -0.15 0 NA
88 hsa-miR-429 AREG 4.49 0 -1.82 0.00455 miRanda -0.19 0.00063 NA
89 hsa-miR-155-5p ARFIP1 1.2 0.00086 -0.25 0.05443 miRNAWalker2 validate -0.11 0 NA
90 hsa-miR-155-5p ARGLU1 1.2 0.00086 0.37 0.05354 miRNAWalker2 validate -0.12 0 NA
91 hsa-miR-28-5p ARHGEF10 0.23 0.07429 -1.15 1.0E-5 miRanda -0.27 0.00764 NA
92 hsa-miR-21-5p ARHGEF12 2.74 0 -0.64 4.0E-5 miRNAWalker2 validate -0.23 0 NA
93 hsa-miR-155-5p ARID2 1.2 0.00086 -0.05 0.73302 miRNAWalker2 validate; miRTarBase -0.16 0 27035278 MicroRNA 155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2
94 hsa-miR-21-5p ARID4A 2.74 0 -0.76 0 miRNAWalker2 validate -0.29 0 NA
95 hsa-miR-429 ARL4A 4.49 0 -0.62 0.01525 miRanda -0.11 0 NA
96 hsa-miR-28-5p ARMC9 0.23 0.07429 -0.17 0.43502 miRanda -0.24 0.00467 NA
97 hsa-miR-21-5p ARMCX3 2.74 0 -0.36 0.05476 miRNAWalker2 validate -0.11 0.00555 NA
98 hsa-miR-28-5p ASCC3 0.23 0.07429 -0.05 0.75233 miRanda -0.33 0 NA
99 hsa-miR-21-5p ASRGL1 2.74 0 -0.33 0.41431 miRNAWalker2 validate -0.21 0.02195 NA
100 hsa-miR-15a-5p ASXL2 2.35 0 -0.51 0.09339 miRNAWalker2 validate -0.26 1.0E-5 NA
101 hsa-miR-21-5p ATAD2B 2.74 0 0.21 0.16127 miRNAWalker2 validate -0.11 0.00173 NA
102 hsa-miR-15a-5p ATF2 2.35 0 -0.36 0.09137 miRNAWalker2 validate -0.17 4.0E-5 NA
103 hsa-miR-484 ATP2A2 1.82 0 -0.4 0.01225 miRNAWalker2 validate -0.11 0.00112 NA
104 hsa-miR-21-5p ATP2B4 2.74 0 -1.72 0 miRNAWalker2 validate -0.33 0 NA
105 hsa-miR-28-5p ATP8A1 0.23 0.07429 -1.48 8.0E-5 miRanda -0.41 0.00477 NA
106 hsa-miR-28-5p ATP8B2 0.23 0.07429 -1.89 0 miRanda -0.4 0.0021 NA
107 hsa-miR-21-5p ATRX 2.74 0 -0.65 1.0E-5 miRNAWalker2 validate -0.21 0 NA
108 hsa-miR-28-5p ATXN1 0.23 0.07429 -1.51 0 miRanda -0.29 0.00632 NA
109 hsa-miR-28-5p ATXN3 0.23 0.07429 -0.21 0.05132 miRanda -0.13 0.0015 NA
110 hsa-miR-21-5p AUTS2 2.74 0 -0.7 0.0585 miRNAWalker2 validate -0.25 0.00226 NA
111 hsa-miR-15b-5p AXIN2 1.57 0 -1.7 6.0E-5 miRTarBase -0.56 0 NA
112 hsa-miR-375 AXL 1.14 0.05123 -1.77 0 miRNAWalker2 validate -0.16 0 NA
113 hsa-miR-21-5p B3GALNT1 2.74 0 0.19 0.4689 miRNAWalker2 validate -0.16 0.00667 NA
114 hsa-miR-15a-5p BACE1 2.35 0 -0.72 0.00096 miRNAWalker2 validate -0.3 0 NA
115 hsa-miR-375 BATF2 1.14 0.05123 0.06 0.89203 miRNAWalker2 validate -0.1 0.00897 NA
116 hsa-miR-107 BBOX1 1.31 0 0.07 0.91587 miRanda -0.52 0.00109 NA
117 hsa-miR-28-5p BBX 0.23 0.07429 -0.51 0.00131 miRanda -0.12 0.04321 NA
118 hsa-miR-484 BBX 1.82 0 -0.51 0.00131 miRNAWalker2 validate -0.17 0 NA
119 hsa-miR-15a-5p BCL2 2.35 0 -2.02 0 miRNAWalker2 validate; miRTarBase -0.39 0 25594541; 26915294; 18931683; 25623762; 22335947 MicroRNAs miRNAs encoded by the miR-15 cluster are known to induce G1 arrest and apoptosis by targeting G1 checkpoints and the anti-apoptotic B cell lymphoma 2 BCL-2 gene;As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;MicroRNAs miRNAs are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2;miR 15a and miR 16 modulate drug resistance by targeting bcl 2 in human colon cancer cells; To investigate the reversal effect of targeted modulation of bcl-2 expression by miR-15a and miR-16 on drug resistance of human colon cancer cells;The expression of MiR-15a was significantly inhibited by Bcl-2 P < 0.05
120 hsa-miR-15b-5p BCL2 1.57 0 -2.02 0 miRNAWalker2 validate; miRTarBase -0.26 3.0E-5 25594541; 26915294; 26884837; 18449891 MicroRNAs miRNAs encoded by the miR-15 cluster are known to induce G1 arrest and apoptosis by targeting G1 checkpoints and the anti-apoptotic B cell lymphoma 2 BCL-2 gene;As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;MiR 15b mediates liver cancer cells proliferation through targeting BCL 2; MiR-15b overexpression downregulated BCL2 mRNA and protein expression obviously P < 0.05; On the contrary miR-15b inhibitor transfection markedly reduced miR-15b expression in liver cancer cells P < 0.05 promoted tumor cell proliferation and increased BCL2 mRNA and protein expression; MiR-15b can inhibit HepG2 cell proliferation and down-regulate BCL2 mRNA and protein expression;miR 15b and miR 16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells; The downregulation of miR-15b and miR-16 in SGC7901/VCR cells was concurrent with the upregulation of Bcl-2 protein; Taken together our findings suggest that miR-15b and miR-16 could play a role in the development of MDR in gastric cancer cells at least in part by modulation of apoptosis via targeting BCL2
121 hsa-miR-200b-3p BCL2 3.78 0 -2.02 0 miRNAWalker2 validate; miRTarBase -0.15 0 NA
122 hsa-miR-21-5p BCL2 2.74 0 -2.02 0 miRNAWalker2 validate; miRTarBase -0.37 0 21468550; 25994220; 25381586; 26555418; 23359184; 22964582; 21376256 BCL-2 up-regulation could be achieved by miR-21 overexpression which prevented T24 cells from apoptosis induced by doxorubicin; Furthermore the miR-21 induced BCL-2 up-regulation could be cancelled by the PI3K inhibitor LY294002;Meanwhile miR-21 loss reduced STAT3 and Bcl-2 activation causing an increase in the apoptosis of tumour cells in CAC mice;Changes in the sensitivity of osteosarcoma cells to CDDP were examined after transfection with miR-21 mimics or anti-miR-21 or bcl-2 siRNA in combination with CDDP;The expression of Bax Bcl-2 and miR-21 in parental and paclitaxel-resistant cells was detected by RT-PCR and Western blotting;Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR 21 regulation of BCL 2 expression; We also used Western blot to measure BCL-2 protein levels after down-regulation of miR-21 expression; Besides down-regulation of miR-21 expression can inhibit BCL-2 expression in PANC-1 CFPAC-1 and MIA Paca-2 cells; Over-expression of miR-21 expression can reverse down-regulation of BCL-2 expression and apoptosis induced by resveratrol; In this study we demonstrated that the effect of resveratrol on apoptosis is due to inhibiting miR-21 regulation of BCL-2 expression;Tumors harvested from these lungs have elevated levels of oncogenic miRNAs miR-21 and miR-155; are deficient for p53-regulated miRNAs; and have heightened expression of miR-34 target genes such as Met and Bcl-2;Bcl 2 upregulation induced by miR 21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa 2 pancreatic cancer cells; However the roles and mechanisms of miRNA miR-21 in regulation of Bcl-2 in pancreatic cancer remain to be elucidated; Then luciferase activity was observed after miR-21 mimics and pRL-TK plasmids containing wild-type and mutant 3'UTRs of Bcl-2 mRNA were co-transfected; Cells transfected with miR-21 inhibitor revealed an opposite trend. There was a significant increase in luciferase activity in the cells transfected with the wild-type pRL-TK plasmid in contrast to those transfected with the mutant one indicating that miR-21 promotes Bcl-2 expression by binding directly to the 3'UTR of Bcl-2 mRNA; Upregulation of Bcl-2 directly induced by miR-21 is associated with apoptosis chemoresistance and proliferation of MIA PaCa-2 pancreatic cancer cells
123 hsa-miR-155-5p BCL6 1.2 0.00086 -0.56 0.00743 miRNAWalker2 validate; miRTarBase -0.15 0 23169640 We show that Bcl6 is indirectly regulated by miR-155 through Mxd1/Mad1 up-regulation; Interestingly we found that miR-155 directly targets HDAC4 a corepressor partner of BCL6; Meta-analysis of the diffuse large B-cell lymphoma patient microarray data showed that miR-155 expression is inversely correlated with Bcl6 and Hdac4; Hence this study provides a better understanding of how miR-155 causes disruption of the BCL6 transcriptional machinery that leads to up-regulation of the survival and proliferation genes in miR-155-induced leukemias
124 hsa-miR-21-5p BCL6 2.74 0 -0.56 0.00743 miRNAWalker2 validate -0.14 0.00187 NA
125 hsa-miR-28-5p BEGAIN 0.23 0.07429 -1.37 0.00071 miRanda -0.37 0.01982 NA
126 hsa-miR-15b-5p BEX1 1.57 0 -2.41 0 miRNAWalker2 validate -0.59 0 NA
127 hsa-miR-28-5p BGN 0.23 0.07429 0.61 0.11201 miRanda -0.31 0.03563 NA
128 hsa-miR-28-5p BHLHE40 0.23 0.07429 -0.75 0.00869 miRanda -0.4 0.00031 NA
129 hsa-miR-28-5p BICC1 0.23 0.07429 -1.47 0.01393 miRanda -0.6 0.01018 NA
130 hsa-miR-21-5p BMPR2 2.74 0 -0.59 4.0E-5 miRNAWalker2 validate; miRTarBase -0.13 3.0E-5 NA
131 hsa-miR-21-5p BOC 2.74 0 -2.87 0 miRNAWalker2 validate -0.41 0 NA
132 hsa-miR-148a-3p BTBD3 1.27 0 -0.6 0.00457 miRNAWalker2 validate -0.12 0.00126 NA
133 hsa-miR-21-5p BTBD3 2.74 0 -0.6 0.00457 miRNAWalker2 validate -0.26 0 NA
134 hsa-miR-21-5p BTBD7 2.74 0 -0.3 0.03144 miRNAWalker2 validate -0.17 0 NA
135 hsa-miR-28-5p BTG1 0.23 0.07429 -0.8 2.0E-5 miRanda -0.18 0.01707 NA
136 hsa-miR-484 BTG1 1.82 0 -0.8 2.0E-5 miRNAWalker2 validate -0.13 0.0008 NA
137 hsa-miR-21-5p BTG2 2.74 0 -2.39 0 miRNAWalker2 validate; miRTarBase -0.73 0 24821435 miR 21 regulates N methyl N nitro N' nitrosoguanidine induced gastric tumorigenesis by targeting FASLG and BTG2
138 hsa-miR-193a-3p C7 1.6 0 -6.76 0 miRanda -0.36 0.00768 NA
139 hsa-miR-330-5p C7 1.15 0 -6.76 0 miRanda -0.84 1.0E-5 NA
140 hsa-miR-375 C7 1.14 0.05123 -6.76 0 miRanda -0.2 0.00587 NA
141 hsa-miR-421 C7 1.18 1.0E-5 -6.76 0 miRanda -0.77 0 NA
142 hsa-miR-590-3p C7 2.59 0 -6.76 0 miRanda -1.3 0 NA
143 hsa-miR-590-5p C7 3.18 0 -6.76 0 miRanda -1.23 0 NA
144 hsa-miR-155-5p CAB39L 1.2 0.00086 -1.33 0.00163 miRNAWalker2 validate -0.47 0 NA
145 hsa-miR-342-3p CAB39L 1.49 0 -1.33 0.00163 miRanda -0.35 0 NA
146 hsa-miR-362-3p CAB39L 2.08 0 -1.33 0.00163 miRanda -0.23 0.0007 NA
147 hsa-miR-590-3p CAB39L 2.59 0 -1.33 0.00163 miRanda -0.27 0.00023 NA
148 hsa-miR-590-5p CAB39L 3.18 0 -1.33 0.00163 miRanda -0.22 0.00104 NA
149 hsa-miR-28-5p CACNA2D3 0.23 0.07429 -1.05 0.019 miRanda -0.36 0.03848 NA
150 hsa-miR-15a-5p CADM1 2.35 0 -1.19 0.01251 miRNAWalker2 validate; miRTarBase -0.27 0.00399 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 211 1848 1.868e-27 8.69e-24
2 REGULATION OF CELL PROLIFERATION 182 1496 8.988e-27 2.091e-23
3 RESPONSE TO ENDOGENOUS STIMULUS 177 1450 3.482e-26 5.401e-23
4 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 140 1008 4.701e-26 5.469e-23
5 REGULATION OF CELL DIFFERENTIATION 172 1492 1.204e-22 1.12e-19
6 VASCULATURE DEVELOPMENT 82 469 9.739e-22 4.943e-19
7 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 142 1142 1.062e-21 4.943e-19
8 CARDIOVASCULAR SYSTEM DEVELOPMENT 112 788 1.051e-21 4.943e-19
9 CIRCULATORY SYSTEM DEVELOPMENT 112 788 1.051e-21 4.943e-19
10 TISSUE DEVELOPMENT 172 1518 7.841e-22 4.943e-19
11 REGULATION OF CELL DEATH 168 1472 1.202e-21 5.085e-19
12 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 191 1784 1.993e-21 7.728e-19
13 REGULATION OF CELLULAR COMPONENT MOVEMENT 108 771 1.848e-20 6.615e-18
14 POSITIVE REGULATION OF CELL DIFFERENTIATION 112 823 3.378e-20 1.123e-17
15 POSITIVE REGULATION OF GENE EXPRESSION 182 1733 1.74e-19 5.181e-17
16 CELL DEVELOPMENT 159 1426 1.781e-19 5.181e-17
17 RESPONSE TO OXYGEN CONTAINING COMPOUND 155 1381 2.941e-19 8.051e-17
18 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 98 689 4.237e-19 1.095e-16
19 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 175 1672 1.424e-18 3.488e-16
20 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 154 1395 1.863e-18 4.334e-16
21 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 183 1805 5.57e-18 1.234e-15
22 RESPONSE TO HORMONE 113 893 6.337e-18 1.34e-15
23 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 121 1004 1.821e-17 3.684e-15
24 POSITIVE REGULATION OF RESPONSE TO STIMULUS 190 1929 2.385e-17 4.624e-15
25 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 122 1021 2.586e-17 4.813e-15
26 REGULATION OF PHOSPHORUS METABOLIC PROCESS 167 1618 3.924e-17 7.022e-15
27 POSITIVE REGULATION OF LOCOMOTION 69 420 5.555e-17 9.573e-15
28 NEGATIVE REGULATION OF CELL PROLIFERATION 89 643 1.122e-16 1.865e-14
29 RESPONSE TO GROWTH FACTOR 73 475 2.769e-16 4.443e-14
30 POSITIVE REGULATION OF CELL COMMUNICATION 158 1532 3.494e-16 5.42e-14
31 BLOOD VESSEL MORPHOGENESIS 62 364 3.831e-16 5.75e-14
32 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 101 799 4.515e-16 6.565e-14
33 CELLULAR RESPONSE TO HORMONE STIMULUS 79 552 9.803e-16 1.382e-13
34 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 47 229 1.061e-15 1.427e-13
35 EPITHELIUM DEVELOPMENT 112 945 1.074e-15 1.427e-13
36 NEGATIVE REGULATION OF CELL DEATH 106 872 1.207e-15 1.561e-13
37 UROGENITAL SYSTEM DEVELOPMENT 54 299 2.517e-15 3.166e-13
38 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 112 957 2.622e-15 3.211e-13
39 RESPONSE TO ORGANIC CYCLIC COMPOUND 108 917 5.624e-15 6.71e-13
40 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 163 1656 7.543e-15 8.775e-13
41 POSITIVE REGULATION OF CELL PROLIFERATION 99 814 1.105e-14 1.254e-12
42 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 133 1275 4.62e-14 5.119e-12
43 REGULATION OF CELL ADHESION 82 629 5.7e-14 6.167e-12
44 REGULATION OF PROTEIN MODIFICATION PROCESS 164 1710 6.015e-14 6.361e-12
45 ORGAN MORPHOGENESIS 99 841 8.662e-14 8.956e-12
46 RESPONSE TO NITROGEN COMPOUND 100 859 1.29e-13 1.281e-11
47 SKELETAL SYSTEM DEVELOPMENT 66 455 1.294e-13 1.281e-11
48 LOCOMOTION 119 1114 2.317e-13 2.246e-11
49 ANGIOGENESIS 50 293 2.68e-13 2.545e-11
50 NEUROGENESIS 140 1402 2.746e-13 2.556e-11
51 REGULATION OF KINASE ACTIVITY 92 776 4.61e-13 4.206e-11
52 PROTEIN PHOSPHORYLATION 105 944 5.596e-13 5.007e-11
53 RESPONSE TO WOUNDING 74 563 6.755e-13 5.93e-11
54 DEVELOPMENTAL GROWTH 53 333 9.035e-13 7.786e-11
55 RESPONSE TO LIPID 100 888 9.931e-13 8.402e-11
56 MUSCLE STRUCTURE DEVELOPMENT 62 432 1.171e-12 9.73e-11
57 TISSUE MORPHOGENESIS 70 533 3.013e-12 2.46e-10
58 POSITIVE REGULATION OF CELL DEATH 76 605 3.251e-12 2.608e-10
59 NEGATIVE REGULATION OF CELL COMMUNICATION 121 1192 4.707e-12 3.712e-10
60 CELL MOTILITY 94 835 5.112e-12 3.9e-10
61 LOCALIZATION OF CELL 94 835 5.112e-12 3.9e-10
62 TUBE DEVELOPMENT 71 552 5.678e-12 4.194e-10
63 CELLULAR RESPONSE TO NITROGEN COMPOUND 67 505 5.628e-12 4.194e-10
64 RESPONSE TO EXTERNAL STIMULUS 165 1821 5.937e-12 4.316e-10
65 NEGATIVE REGULATION OF GENE EXPRESSION 142 1493 7.183e-12 5.142e-10
66 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 26 100 9.963e-12 7.024e-10
67 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 117 1152 1.069e-11 7.422e-10
68 REGULATION OF GROWTH 77 633 1.164e-11 7.735e-10
69 GROWTH 58 410 1.155e-11 7.735e-10
70 TUBE MORPHOGENESIS 50 323 1.149e-11 7.735e-10
71 REGULATION OF VASCULATURE DEVELOPMENT 41 233 1.391e-11 9.118e-10
72 REGULATION OF EPITHELIAL CELL PROLIFERATION 46 285 1.789e-11 1.156e-09
73 INTRACELLULAR SIGNAL TRANSDUCTION 146 1572 2.041e-11 1.301e-09
74 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 65 498 2.421e-11 1.522e-09
75 BIOLOGICAL ADHESION 107 1032 2.606e-11 1.617e-09
76 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 107 1036 3.287e-11 1.986e-09
77 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 107 1036 3.287e-11 1.986e-09
78 REGULATION OF TRANSPORT 161 1804 3.699e-11 2.207e-09
79 REGULATION OF TRANSFERASE ACTIVITY 100 946 4.119e-11 2.426e-09
80 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 130 1360 4.492e-11 2.613e-09
81 EXTRACELLULAR STRUCTURE ORGANIZATION 47 304 5.001e-11 2.873e-09
82 NEPHRON DEVELOPMENT 27 115 5.226e-11 2.93e-09
83 EPITHELIAL CELL DIFFERENTIATION 64 495 5.2e-11 2.93e-09
84 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 139 1492 5.378e-11 2.979e-09
85 PHOSPHORYLATION 120 1228 6.887e-11 3.77e-09
86 HEART DEVELOPMENT 61 466 8.955e-11 4.845e-09
87 MUSCLE CELL DIFFERENTIATION 40 237 9.298e-11 4.973e-09
88 EMBRYO DEVELOPMENT 95 894 9.868e-11 5.218e-09
89 CONNECTIVE TISSUE DEVELOPMENT 35 194 2.138e-10 1.118e-08
90 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 81 724 2.23e-10 1.153e-08
91 MUSCLE TISSUE DEVELOPMENT 43 275 2.308e-10 1.18e-08
92 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 82 740 2.744e-10 1.388e-08
93 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 169 1977 3.294e-10 1.648e-08
94 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 36 207 3.426e-10 1.696e-08
95 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 28 133 3.529e-10 1.728e-08
96 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 92 876 3.683e-10 1.785e-08
97 RESPONSE TO STEROID HORMONE 62 497 4.545e-10 2.18e-08
98 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 29 144 5.214e-10 2.476e-08
99 EMBRYONIC MORPHOGENESIS 65 539 7.05e-10 3.313e-08
100 RESPONSE TO INORGANIC SUBSTANCE 60 479 7.429e-10 3.439e-08
101 RESPONSE TO ABIOTIC STIMULUS 102 1024 7.465e-10 3.439e-08
102 REGULATION OF CELLULAR LOCALIZATION 120 1277 7.821e-10 3.568e-08
103 REGULATION OF CELL DEVELOPMENT 88 836 8.122e-10 3.669e-08
104 CARTILAGE DEVELOPMENT 29 147 8.68e-10 3.847e-08
105 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 28 138 8.637e-10 3.847e-08
106 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 24 104 8.922e-10 3.916e-08
107 MORPHOGENESIS OF A BRANCHING STRUCTURE 31 167 1.109e-09 4.824e-08
108 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 136 1517 1.166e-09 5.025e-08
109 CARDIAC MUSCLE TISSUE DEVELOPMENT 28 140 1.22e-09 5.206e-08
110 REGULATION OF CELL GROWTH 52 391 1.275e-09 5.393e-08
111 CENTRAL NERVOUS SYSTEM DEVELOPMENT 90 872 1.395e-09 5.846e-08
112 CELLULAR COMPONENT MORPHOGENESIS 92 900 1.477e-09 6.137e-08
113 MESENCHYME DEVELOPMENT 33 190 1.921e-09 7.911e-08
114 WOUND HEALING 58 470 2.517e-09 1.026e-07
115 GLOMERULUS DEVELOPMENT 16 49 2.536e-09 1.026e-07
116 BONE DEVELOPMENT 29 156 3.671e-09 1.473e-07
117 REGULATION OF ACTIN FILAMENT BASED PROCESS 44 312 3.964e-09 1.577e-07
118 REGULATION OF CELL MORPHOGENESIS 64 552 4.623e-09 1.823e-07
119 POSITIVE REGULATION OF GROWTH 37 238 4.87e-09 1.904e-07
120 REGULATION OF PROTEIN LOCALIZATION 94 950 5.081e-09 1.97e-07
121 CELLULAR RESPONSE TO LIPID 56 457 6.132e-09 2.358e-07
122 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 57 470 6.541e-09 2.495e-07
123 REGULATION OF MAPK CASCADE 72 660 6.818e-09 2.579e-07
124 CELLULAR RESPONSE TO PEPTIDE 40 274 7.466e-09 2.802e-07
125 POSITIVE REGULATION OF CELL DEVELOPMENT 57 472 7.631e-09 2.841e-07
126 MORPHOGENESIS OF AN EPITHELIUM 51 400 7.816e-09 2.887e-07
127 ACTIN FILAMENT BASED PROCESS 55 450 9.188e-09 3.366e-07
128 KIDNEY EPITHELIUM DEVELOPMENT 25 125 9.333e-09 3.393e-07
129 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 60 513 1.023e-08 3.69e-07
130 REGULATION OF CELL SUBSTRATE ADHESION 30 173 1.077e-08 3.853e-07
131 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 106 1135 1.165e-08 4.137e-07
132 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 95 983 1.357e-08 4.784e-07
133 FORMATION OF PRIMARY GERM LAYER 23 110 1.502e-08 5.254e-07
134 POSITIVE REGULATION OF MOLECULAR FUNCTION 150 1791 1.524e-08 5.291e-07
135 CELL MATRIX ADHESION 24 119 1.549e-08 5.308e-07
136 DEVELOPMENTAL CELL GROWTH 19 77 1.551e-08 5.308e-07
137 NEURON PROJECTION DEVELOPMENT 62 545 1.66e-08 5.638e-07
138 DIGESTIVE SYSTEM DEVELOPMENT 27 148 1.914e-08 6.455e-07
139 CYTOSKELETON ORGANIZATION 84 838 1.945e-08 6.51e-07
140 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 13 36 1.998e-08 6.594e-07
141 RESPONSE TO OXIDATIVE STRESS 46 352 1.985e-08 6.594e-07
142 REGULATION OF OSSIFICATION 30 178 2.118e-08 6.941e-07
143 REGULATION OF OSTEOBLAST DIFFERENTIATION 23 112 2.152e-08 7.001e-07
144 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 81 801 2.399e-08 7.753e-07
145 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 25 131 2.513e-08 8.063e-07
146 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 31 190 2.709e-08 8.632e-07
147 RESPONSE TO PEPTIDE 50 404 2.906e-08 9.197e-07
148 RESPONSE TO REACTIVE OXYGEN SPECIES 31 191 3.071e-08 9.654e-07
149 RESPONSE TO OXYGEN LEVELS 42 311 3.188e-08 9.955e-07
150 CELL PROLIFERATION 71 672 3.22e-08 9.987e-07
151 PATTERN SPECIFICATION PROCESS 51 418 3.376e-08 1.04e-06
152 GLAND DEVELOPMENT 49 395 3.711e-08 1.136e-06
153 STRIATED MUSCLE CELL DIFFERENTIATION 29 173 4.104e-08 1.248e-06
154 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 27 154 4.566e-08 1.371e-06
155 NEGATIVE REGULATION OF MOLECULAR FUNCTION 100 1079 4.568e-08 1.371e-06
156 CARDIAC MUSCLE CELL DIFFERENTIATION 18 74 4.701e-08 1.393e-06
157 CELL GROWTH 25 135 4.69e-08 1.393e-06
158 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 21 99 4.844e-08 1.418e-06
159 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 21 99 4.844e-08 1.418e-06
160 REGULATION OF LIPID METABOLIC PROCESS 39 282 5.164e-08 1.502e-06
161 GLIOGENESIS 29 175 5.325e-08 1.539e-06
162 POSITIVE REGULATION OF CELL ADHESION 47 376 5.572e-08 1.6e-06
163 NEGATIVE REGULATION OF ANOIKIS 9 17 5.719e-08 1.633e-06
164 CELLULAR RESPONSE TO INSULIN STIMULUS 26 146 5.821e-08 1.652e-06
165 HEAD DEVELOPMENT 73 709 5.885e-08 1.66e-06
166 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 27 156 6.034e-08 1.691e-06
167 NEURON DIFFERENTIATION 85 874 6.216e-08 1.732e-06
168 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 54 465 7.127e-08 1.974e-06
169 REGULATION OF CELLULAR COMPONENT BIOGENESIS 77 767 7.298e-08 2.009e-06
170 POSITIVE REGULATION OF CATALYTIC ACTIVITY 129 1518 7.887e-08 2.152e-06
171 CELL JUNCTION ASSEMBLY 24 129 7.908e-08 2.152e-06
172 FOREBRAIN DEVELOPMENT 45 357 8.334e-08 2.254e-06
173 MYELOID CELL DIFFERENTIATION 30 189 8.521e-08 2.292e-06
174 REGULATION OF BMP SIGNALING PATHWAY 18 77 9.083e-08 2.429e-06
175 REGULATION OF DEVELOPMENTAL GROWTH 39 289 1.004e-07 2.669e-06
176 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 88 926 1.022e-07 2.702e-06
177 NEGATIVE REGULATION OF CELL CYCLE 51 433 1.052e-07 2.766e-06
178 RENAL TUBULE DEVELOPMENT 18 78 1.122e-07 2.934e-06
179 NEGATIVE REGULATION OF PHOSPHORYLATION 50 422 1.165e-07 3.028e-06
180 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 27 162 1.349e-07 3.487e-06
181 CARDIOCYTE DIFFERENTIATION 20 96 1.378e-07 3.544e-06
182 REGULATION OF ORGANELLE ORGANIZATION 105 1178 1.472e-07 3.764e-06
183 REGULATION OF CELL CYCLE 89 949 1.558e-07 3.962e-06
184 CELL FATE COMMITMENT 33 227 1.677e-07 4.241e-06
185 CELL SUBSTRATE ADHESION 27 164 1.746e-07 4.393e-06
186 CELL CYCLE ARREST 26 154 1.761e-07 4.405e-06
187 IMMUNE SYSTEM DEVELOPMENT 62 582 1.823e-07 4.535e-06
188 CELL JUNCTION ORGANIZATION 29 185 1.835e-07 4.543e-06
189 NEGATIVE REGULATION OF CELL DIFFERENTIATION 64 609 1.888e-07 4.649e-06
190 KIDNEY VASCULATURE DEVELOPMENT 9 19 1.971e-07 4.803e-06
191 RENAL SYSTEM VASCULATURE DEVELOPMENT 9 19 1.971e-07 4.803e-06
192 GASTRULATION 26 155 2.01e-07 4.871e-06
193 COGNITION 35 251 2.022e-07 4.874e-06
194 SMOOTH MUSCLE CELL DIFFERENTIATION 11 30 2.082e-07 4.969e-06
195 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 11 30 2.082e-07 4.969e-06
196 MESONEPHROS DEVELOPMENT 19 90 2.264e-07 5.374e-06
197 REGULATION OF WNT SIGNALING PATHWAY 40 310 2.33e-07 5.504e-06
198 CELL PROJECTION ORGANIZATION 85 902 2.446e-07 5.748e-06
199 SINGLE ORGANISM BEHAVIOR 46 384 2.711e-07 6.34e-06
200 RESPONSE TO ALCOHOL 44 362 3.271e-07 7.609e-06
201 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 50 437 3.425e-07 7.928e-06
202 HEART MORPHOGENESIS 31 212 3.455e-07 7.959e-06
203 NEURON DEVELOPMENT 69 687 3.483e-07 7.984e-06
204 WNT SIGNALING PATHWAY 43 351 3.576e-07 8.156e-06
205 REGULATION OF NEURON DIFFERENTIATION 59 554 3.655e-07 8.296e-06
206 POSITIVE REGULATION OF OSSIFICATION 18 84 3.703e-07 8.364e-06
207 NEPHRON EPITHELIUM DEVELOPMENT 19 93 3.891e-07 8.746e-06
208 BEHAVIOR 56 516 3.943e-07 8.822e-06
209 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 22 121 4.131e-07 9.153e-06
210 NEURON PROJECTION MORPHOGENESIS 47 402 4.116e-07 9.153e-06
211 ORGAN GROWTH 16 68 4.259e-07 9.391e-06
212 RESPONSE TO BMP 19 94 4.635e-07 1.012e-05
213 CELLULAR RESPONSE TO BMP STIMULUS 19 94 4.635e-07 1.012e-05
214 REGULATION OF CYTOPLASMIC TRANSPORT 53 481 5.039e-07 1.094e-05
215 REGULATION OF CELL CELL ADHESION 45 380 5.055e-07 1.094e-05
216 ANTERIOR POSTERIOR PATTERN SPECIFICATION 29 194 5.131e-07 1.105e-05
217 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 38 296 5.282e-07 1.133e-05
218 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 73 750 5.315e-07 1.134e-05
219 REGULATION OF CHONDROCYTE DIFFERENTIATION 13 46 5.337e-07 1.134e-05
220 CARDIAC CHAMBER MORPHOGENESIS 20 104 5.418e-07 1.146e-05
221 NEGATIVE REGULATION OF KINASE ACTIVITY 34 250 5.45e-07 1.147e-05
222 POSITIVE REGULATION OF MAPK CASCADE 52 470 5.692e-07 1.193e-05
223 OSSIFICATION 34 251 5.987e-07 1.249e-05
224 INOSITOL LIPID MEDIATED SIGNALING 22 124 6.401e-07 1.33e-05
225 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 15 62 6.634e-07 1.372e-05
226 REGULATION OF CELLULAR PROTEIN LOCALIZATION 58 552 7.15e-07 1.472e-05
227 CELLULAR MACROMOLECULE LOCALIZATION 106 1234 7.665e-07 1.571e-05
228 CELL DEATH 90 1001 8.365e-07 1.703e-05
229 REGULATION OF CYTOSKELETON ORGANIZATION 54 502 8.38e-07 1.703e-05
230 RESPONSE TO ESTRADIOL 24 146 8.565e-07 1.733e-05
231 DIGESTIVE TRACT MORPHOGENESIS 13 48 9.156e-07 1.844e-05
232 CELL SUBSTRATE JUNCTION ASSEMBLY 12 41 9.637e-07 1.933e-05
233 REGULATION OF CELL PROJECTION ORGANIZATION 58 558 1.016e-06 2.028e-05
234 REGULATION OF PHOSPHOLIPASE ACTIVITY 15 64 1.028e-06 2.045e-05
235 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 43 365 1.038e-06 2.055e-05
236 REGULATION OF FIBROBLAST PROLIFERATION 17 81 1.06e-06 2.091e-05
237 LIPID PHOSPHORYLATION 19 99 1.07e-06 2.1e-05
238 POSITIVE REGULATION OF CELL GROWTH 24 148 1.103e-06 2.156e-05
239 IMMUNE SYSTEM PROCESS 154 1984 1.135e-06 2.21e-05
240 RESPONSE TO HYDROGEN PEROXIDE 20 109 1.182e-06 2.292e-05
241 REGULATION OF BINDING 36 283 1.301e-06 2.512e-05
242 NEURON MIGRATION 20 110 1.374e-06 2.641e-05
243 POSITIVE REGULATION OF CHEMOTAXIS 21 120 1.443e-06 2.764e-05
244 REGULATION OF ERK1 AND ERK2 CASCADE 32 238 1.501e-06 2.863e-05
245 REPRODUCTIVE SYSTEM DEVELOPMENT 46 408 1.513e-06 2.874e-05
246 RESPONSE TO INSULIN 29 205 1.634e-06 3.09e-05
247 REGULATION OF INTRACELLULAR TRANSPORT 62 621 1.681e-06 3.167e-05
248 POSITIVE REGULATION OF AXON EXTENSION 11 36 1.703e-06 3.194e-05
249 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 19 102 1.716e-06 3.207e-05
250 REGULATION OF MUSCLE CELL DIFFERENTIATION 24 152 1.801e-06 3.347e-05
251 REGIONALIZATION 38 311 1.805e-06 3.347e-05
252 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 48 437 1.893e-06 3.496e-05
253 RESPONSE TO ESTROGEN 30 218 1.949e-06 3.584e-05
254 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 40 337 2.031e-06 3.721e-05
255 REGULATION OF RESPONSE TO WOUNDING 46 413 2.115e-06 3.86e-05
256 MUSCLE ORGAN DEVELOPMENT 35 277 2.126e-06 3.864e-05
257 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 9 24 2.188e-06 3.946e-05
258 REGULATION OF ANOIKIS 9 24 2.188e-06 3.946e-05
259 CELLULAR RESPONSE TO ACID CHEMICAL 26 175 2.21e-06 3.955e-05
260 HOMEOSTASIS OF NUMBER OF CELLS 26 175 2.21e-06 3.955e-05
261 PEPTIDYL TYROSINE MODIFICATION 27 186 2.24e-06 3.979e-05
262 RESPIRATORY SYSTEM DEVELOPMENT 28 197 2.236e-06 3.979e-05
263 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 15 68 2.339e-06 4.139e-05
264 PROTEIN LOCALIZATION 141 1805 2.449e-06 4.317e-05
265 RESPONSE TO CORTICOSTEROID 26 176 2.464e-06 4.326e-05
266 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 14 60 2.486e-06 4.349e-05
267 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 37 303 2.495e-06 4.349e-05
268 ACTOMYOSIN STRUCTURE ORGANIZATION 16 77 2.516e-06 4.369e-05
269 REGULATION OF IMMUNE SYSTEM PROCESS 115 1403 2.537e-06 4.388e-05
270 POSITIVE REGULATION OF KINASE ACTIVITY 51 482 2.728e-06 4.701e-05
271 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 27 188 2.759e-06 4.738e-05
272 POSITIVE REGULATION OF AXONOGENESIS 15 69 2.843e-06 4.863e-05
273 REGULATION OF RESPONSE TO STRESS 119 1468 2.872e-06 4.895e-05
274 POSITIVE REGULATION OF NEURON DIFFERENTIATION 37 306 3.151e-06 5.351e-05
275 GLIAL CELL DIFFERENTIATION 22 136 3.187e-06 5.392e-05
276 REGULATION OF PROTEIN BINDING 25 168 3.344e-06 5.618e-05
277 SKELETAL SYSTEM MORPHOGENESIS 28 201 3.335e-06 5.618e-05
278 STEM CELL DIFFERENTIATION 27 190 3.387e-06 5.669e-05
279 MYELOID CELL HOMEOSTASIS 17 88 3.554e-06 5.906e-05
280 REGULATION OF STEM CELL PROLIFERATION 17 88 3.554e-06 5.906e-05
281 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 29 213 3.569e-06 5.909e-05
282 BONE MORPHOGENESIS 16 79 3.589e-06 5.922e-05
283 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 56 554 3.676e-06 6.045e-05
284 RESPONSE TO METAL ION 39 333 3.764e-06 6.157e-05
285 CARDIAC VENTRICLE MORPHOGENESIS 14 62 3.771e-06 6.157e-05
286 POSITIVE REGULATION OF TRANSPORT 83 936 3.89e-06 6.328e-05
287 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 18 98 3.941e-06 6.389e-05
288 REGULATION OF PHOSPHOLIPASE C ACTIVITY 11 39 4.096e-06 6.618e-05
289 TAXIS 49 464 4.502e-06 7.249e-05
290 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 18 99 4.579e-06 7.347e-05
291 REGULATION OF CARTILAGE DEVELOPMENT 14 63 4.612e-06 7.374e-05
292 RESPONSE TO KETONE 26 182 4.633e-06 7.383e-05
293 VESICLE MEDIATED TRANSPORT 103 1239 4.798e-06 7.62e-05
294 ENDOTHELIAL CELL DIFFERENTIATION 15 72 4.984e-06 7.888e-05
295 REGULATION OF APOPTOTIC SIGNALING PATHWAY 41 363 5.308e-06 8.373e-05
296 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 59 602 5.342e-06 8.397e-05
297 CELLULAR RESPONSE TO STRESS 124 1565 5.386e-06 8.438e-05
298 RESPONSE TO EXTRACELLULAR STIMULUS 47 441 5.496e-06 8.582e-05
299 REGULATION OF MUSCLE SYSTEM PROCESS 27 195 5.569e-06 8.666e-05
300 EPIDERMIS DEVELOPMENT 32 253 5.615e-06 8.709e-05
301 ERYTHROCYTE HOMEOSTASIS 15 73 5.966e-06 9.202e-05
302 KIDNEY MORPHOGENESIS 16 82 5.972e-06 9.202e-05
303 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 23 152 6.133e-06 9.419e-05
304 RESPONSE TO DRUG 46 431 6.645e-06 0.0001017
305 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 30 232 7.009e-06 0.0001069
306 REGULATION OF ANATOMICAL STRUCTURE SIZE 49 472 7.204e-06 0.0001095
307 SINGLE ORGANISM CELL ADHESION 48 459 7.326e-06 0.000111
308 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 34 7.436e-06 0.0001116
309 RESPONSE TO PROSTAGLANDIN 10 34 7.436e-06 0.0001116
310 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 41 368 7.427e-06 0.0001116
311 LIPID MODIFICATION 28 210 7.829e-06 0.0001164
312 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 92 1087 7.81e-06 0.0001164
313 RESPONSE TO MECHANICAL STIMULUS 28 210 7.829e-06 0.0001164
314 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 54 541 7.893e-06 0.0001166
315 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 54 541 7.893e-06 0.0001166
316 RESPONSE TO ACID CHEMICAL 37 319 8.273e-06 0.0001218
317 MESENCHYMAL CELL DIFFERENTIATION 21 134 8.82e-06 0.0001295
318 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 11 42 9.024e-06 0.0001316
319 REGULATION OF HEART GROWTH 11 42 9.024e-06 0.0001316
320 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 12 50 9.479e-06 0.0001378
321 MUSCLE HYPERTROPHY 9 28 9.518e-06 0.0001378
322 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 37 321 9.538e-06 0.0001378
323 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 41 372 9.658e-06 0.0001391
324 NEGATIVE REGULATION OF GROWTH 30 236 9.868e-06 0.0001417
325 HOMEOSTATIC PROCESS 108 1337 1e-05 0.0001432
326 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 56 573 1.003e-05 0.0001432
327 REGULATION OF SECRETION 65 699 1.009e-05 0.0001436
328 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 17 95 1.044e-05 0.000148
329 RESPONSE TO CYTOKINE 66 714 1.046e-05 0.000148
330 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 16 86 1.131e-05 0.0001595
331 REGULATION OF CHEMOTAXIS 25 180 1.159e-05 0.0001629
332 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 20 126 1.179e-05 0.0001653
333 REGULATION OF GLUCOSE METABOLIC PROCESS 18 106 1.234e-05 0.0001724
334 EYE DEVELOPMENT 37 326 1.352e-05 0.0001883
335 CELLULAR RESPONSE TO EXTERNAL STIMULUS 32 264 1.361e-05 0.0001884
336 AGING 32 264 1.361e-05 0.0001884
337 TELENCEPHALON DEVELOPMENT 29 228 1.364e-05 0.0001884
338 REGULATION OF NEURON DEATH 31 252 1.374e-05 0.0001892
339 REGULATION OF HEMOPOIESIS 36 314 1.41e-05 0.0001928
340 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 34 289 1.406e-05 0.0001928
341 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 14 69 1.413e-05 0.0001928
342 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 11 44 1.465e-05 0.0001994
343 NEGATIVE REGULATION OF TRANSPORT 47 458 1.489e-05 0.0002015
344 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 7 17 1.49e-05 0.0002015
345 MUSCLE CELL DEVELOPMENT 20 128 1.499e-05 0.0002022
346 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 43 406 1.59e-05 0.0002132
347 EMBRYONIC ORGAN DEVELOPMENT 43 406 1.59e-05 0.0002132
348 REGENERATION 23 161 1.613e-05 0.0002157
349 AXON EXTENSION 10 37 1.706e-05 0.0002274
350 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 12 53 1.796e-05 0.000236
351 NEURON PROJECTION EXTENSION 12 53 1.796e-05 0.000236
352 MESONEPHRIC TUBULE MORPHOGENESIS 12 53 1.796e-05 0.000236
353 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 9 30 1.789e-05 0.000236
354 REGULATION OF NEURON PROJECTION DEVELOPMENT 43 408 1.792e-05 0.000236
355 SPROUTING ANGIOGENESIS 11 45 1.846e-05 0.000242
356 INSULIN RECEPTOR SIGNALING PATHWAY 15 80 1.917e-05 0.0002505
357 FOREBRAIN CELL MIGRATION 13 62 1.963e-05 0.0002552
358 EMBRYONIC HEART TUBE MORPHOGENESIS 13 62 1.963e-05 0.0002552
359 REGULATION OF MAP KINASE ACTIVITY 36 319 1.992e-05 0.0002581
360 REPRODUCTION 104 1297 2.004e-05 0.000259
361 ENDOTHELIUM DEVELOPMENT 16 90 2.054e-05 0.0002648
362 REGULATION OF HOMOTYPIC CELL CELL ADHESION 35 307 2.083e-05 0.0002677
363 REGULATION OF CATABOLIC PROCESS 66 731 2.209e-05 0.0002831
364 REGULATION OF MYELOID CELL APOPTOTIC PROCESS 8 24 2.229e-05 0.0002849
365 METANEPHROS DEVELOPMENT 15 81 2.237e-05 0.0002852
366 REGULATION OF SYSTEM PROCESS 50 507 2.34e-05 0.0002975
367 AMEBOIDAL TYPE CELL MIGRATION 22 154 2.447e-05 0.0003103
368 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 19 122 2.549e-05 0.0003223
369 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 26 200 2.556e-05 0.0003223
370 REGULATION OF EPITHELIAL CELL MIGRATION 23 166 2.662e-05 0.0003348
371 CARDIAC CHAMBER DEVELOPMENT 21 144 2.715e-05 0.0003395
372 NEGATIVE REGULATION OF DEFENSE RESPONSE 21 144 2.715e-05 0.0003395
373 EMBRYONIC HEART TUBE DEVELOPMENT 14 73 2.768e-05 0.0003443
374 REGULATION OF ORGAN GROWTH 14 73 2.768e-05 0.0003443
375 REGULATION OF LIPASE ACTIVITY 15 83 3.024e-05 0.0003727
376 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 38 351 3.011e-05 0.0003727
377 RESPONSE TO FATTY ACID 15 83 3.024e-05 0.0003727
378 REGULATION OF STEM CELL DIFFERENTIATION 18 113 3.028e-05 0.0003727
379 PEPTIDYL AMINO ACID MODIFICATION 73 841 3.062e-05 0.0003759
380 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 42 404 3.087e-05 0.000378
381 CELL ACTIVATION 54 568 3.098e-05 0.0003784
382 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 25 3.124e-05 0.0003798
383 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 17 103 3.126e-05 0.0003798
384 NEGATIVE REGULATION OF LOCOMOTION 31 263 3.194e-05 0.0003871
385 REGULATION OF AXONOGENESIS 23 168 3.231e-05 0.0003905
386 MODULATION OF SYNAPTIC TRANSMISSION 34 301 3.29e-05 0.0003966
387 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 15 84 3.501e-05 0.0004197
388 FIBRIL ORGANIZATION 7 19 3.512e-05 0.0004197
389 REGULATION OF LIPID KINASE ACTIVITY 11 48 3.546e-05 0.0004197
390 REGULATION OF NEURON APOPTOTIC PROCESS 25 192 3.533e-05 0.0004197
391 APPENDAGE DEVELOPMENT 23 169 3.554e-05 0.0004197
392 MYOFIBRIL ASSEMBLY 11 48 3.546e-05 0.0004197
393 LIMB DEVELOPMENT 23 169 3.554e-05 0.0004197
394 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 7 19 3.512e-05 0.0004197
395 FORELIMB MORPHOGENESIS 10 40 3.586e-05 0.0004224
396 RESPONSE TO PURINE CONTAINING COMPOUND 22 158 3.661e-05 0.0004301
397 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 20 136 3.701e-05 0.0004338
398 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 18 115 3.854e-05 0.0004505
399 MESODERM MORPHOGENESIS 13 66 3.961e-05 0.000462
400 SEX DIFFERENTIATION 31 266 3.978e-05 0.0004627
401 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 57 616 4.045e-05 0.0004693
402 MALE SEX DIFFERENTIATION 21 148 4.114e-05 0.0004762
403 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 27 218 4.286e-05 0.000494
404 NEGATIVE REGULATION OF NEURON DEATH 23 171 4.289e-05 0.000494
405 MESODERMAL CELL DIFFERENTIATION 8 26 4.302e-05 0.0004942
406 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 11 49 4.354e-05 0.0004978
407 CARDIAC SEPTUM MORPHOGENESIS 11 49 4.354e-05 0.0004978
408 REGULATION OF PROTEIN IMPORT 24 183 4.471e-05 0.0005098
409 REGULATION OF BODY FLUID LEVELS 49 506 4.491e-05 0.0005109
410 CELL PART MORPHOGENESIS 58 633 4.577e-05 0.0005195
411 SENSORY ORGAN DEVELOPMENT 48 493 4.679e-05 0.0005298
412 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 74 867 4.696e-05 0.0005302
413 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 23 172 4.706e-05 0.0005302
414 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 14 4.789e-05 0.0005383
415 CELLULAR RESPONSE TO STARVATION 18 117 4.874e-05 0.0005464
416 CELLULAR RESPONSE TO OXIDATIVE STRESS 24 184 4.886e-05 0.0005465
417 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 27 220 5.031e-05 0.0005611
418 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 19 128 5.04e-05 0.0005611
419 REGULATION OF HYDROLASE ACTIVITY 104 1327 5.056e-05 0.0005615
420 RESPONSE TO RADIATION 42 413 5.146e-05 0.000568
421 ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 7 20 5.153e-05 0.000568
422 PLATELET DEGRANULATION 17 107 5.163e-05 0.000568
423 MELANOCYTE DIFFERENTIATION 7 20 5.153e-05 0.000568
424 ENDOCYTOSIS 49 509 5.214e-05 0.0005722
425 GLAND MORPHOGENESIS 16 97 5.341e-05 0.0005848
426 RESPONSE TO FLUID SHEAR STRESS 9 34 5.406e-05 0.0005905
427 VASCULOGENESIS 12 59 5.602e-05 0.0006104
428 EPITHELIAL CELL DEVELOPMENT 24 186 5.821e-05 0.0006321
429 POSITIVE REGULATION OF HEART GROWTH 8 27 5.828e-05 0.0006321
430 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 23 175 6.181e-05 0.0006688
431 POSITIVE REGULATION OF HYDROLASE ACTIVITY 76 905 6.327e-05 0.0006831
432 IN UTERO EMBRYONIC DEVELOPMENT 34 311 6.377e-05 0.0006853
433 NEGATIVE REGULATION OF CELL ADHESION 27 223 6.369e-05 0.0006853
434 CHONDROCYTE DIFFERENTIATION 12 60 6.665e-05 0.0007146
435 PALLIUM DEVELOPMENT 21 153 6.751e-05 0.0007221
436 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 14 79 6.907e-05 0.0007371
437 RESPONSE TO MONOAMINE 9 35 6.934e-05 0.0007383
438 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 10 43 7.008e-05 0.0007444
439 EPITHELIAL CELL PROLIFERATION 15 89 7.026e-05 0.0007447
440 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 6 15 7.621e-05 0.0008059
441 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 8 28 7.778e-05 0.0008191
442 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 16 100 7.798e-05 0.0008191
443 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 100 7.798e-05 0.0008191
444 SECRETION 54 588 7.819e-05 0.0008194
445 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 18 122 8.538e-05 0.0008928
446 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 9 36 8.81e-05 0.0009191
447 GLYCEROLIPID METABOLIC PROCESS 37 356 9.019e-05 0.0009388
448 CELL CYCLE 102 1316 9.175e-05 0.0009508
449 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 14 81 9.163e-05 0.0009508
450 CELLULAR RESPONSE TO CYTOKINE STIMULUS 55 606 9.199e-05 0.0009512
451 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 11 53 9.361e-05 0.0009637
452 RESPONSE TO CARBOHYDRATE 22 168 9.349e-05 0.0009637
453 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 26 216 9.521e-05 0.0009779
454 EMBRYONIC ORGAN MORPHOGENESIS 31 279 9.789e-05 0.001003
455 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 0.0001024 0.001045
456 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 8 29 0.0001024 0.001045
457 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 70 829 0.0001041 0.00106
458 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 24 193 0.0001049 0.001066
459 ENDOTHELIAL CELL DEVELOPMENT 10 45 0.0001058 0.00107
460 LUNG MORPHOGENESIS 10 45 0.0001058 0.00107
461 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 9 37 0.0001109 0.00112
462 NEGATIVE REGULATION OF CELL GROWTH 22 170 0.0001115 0.001123
463 REGULATION OF MUSCLE TISSUE DEVELOPMENT 16 103 0.000112 0.001123
464 REGULATION OF MUSCLE ORGAN DEVELOPMENT 16 103 0.000112 0.001123
465 REGULATION OF MUSCLE CONTRACTION 20 147 0.0001128 0.001126
466 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 20 147 0.0001128 0.001126
467 REGULATION OF ENDOTHELIAL CELL MIGRATION 17 114 0.0001163 0.001159
468 REGULATION OF CELL ACTIVATION 46 484 0.0001183 0.001176
469 MUSCLE SYSTEM PROCESS 31 282 0.0001192 0.001183
470 CATABOLIC PROCESS 130 1773 0.0001211 0.001199
471 REGULATION OF MYELOID CELL DIFFERENTIATION 23 183 0.0001233 0.001218
472 REGULATION OF LEUKOCYTE DIFFERENTIATION 27 232 0.0001251 0.001233
473 RESPONSE TO CAMP 16 104 0.0001259 0.001238
474 SECOND MESSENGER MEDIATED SIGNALING 21 160 0.0001294 0.00127
475 SECRETION BY CELL 46 486 0.0001302 0.001275
476 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 22 172 0.0001326 0.001296
477 EXOCYTOSIS 33 310 0.0001353 0.00132
478 TISSUE MIGRATION 14 84 0.0001374 0.001337
479 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 9 38 0.0001385 0.001343
480 POSITIVE REGULATION OF ORGAN GROWTH 9 38 0.0001385 0.001343
481 REGULATION OF CELLULAR COMPONENT SIZE 35 337 0.0001402 0.001356
482 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 55 616 0.0001408 0.001359
483 REGULATION OF OSTEOBLAST PROLIFERATION 7 23 0.0001415 0.001363
484 REGULATION OF HOMEOSTATIC PROCESS 43 447 0.0001494 0.001436
485 CYCLOOXYGENASE PATHWAY 5 11 0.000153 0.001468
486 REGULATION OF FAT CELL DIFFERENTIATION 16 106 0.0001582 0.001515
487 NEGATIVE REGULATION OF HEMOPOIESIS 18 128 0.0001598 0.001527
488 SPECIFICATION OF SYMMETRY 17 117 0.000161 0.001535
489 SKIN DEVELOPMENT 25 211 0.0001654 0.001574
490 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 27 236 0.0001663 0.001579
491 REGULATION OF CYTOKINE PRODUCTION 51 563 0.0001715 0.001608
492 BRANCH ELONGATION OF AN EPITHELIUM 6 17 0.0001718 0.001608
493 INTESTINAL EPITHELIAL CELL DIFFERENTIATION 6 17 0.0001718 0.001608
494 MAMMARY GLAND ALVEOLUS DEVELOPMENT 6 17 0.0001718 0.001608
495 MAMMARY GLAND LOBULE DEVELOPMENT 6 17 0.0001718 0.001608
496 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 17 0.0001718 0.001608
497 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 9 39 0.0001716 0.001608
498 POSITIVE REGULATION OF LIPASE ACTIVITY 12 66 0.0001745 0.00163
499 MESODERM DEVELOPMENT 17 118 0.0001789 0.001668
500 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 10 48 0.0001874 0.001744
501 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 7 24 0.0001906 0.00177
502 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 20 153 0.000196 0.001816
503 REGULATION OF ION HOMEOSTASIS 24 201 0.0001969 0.001822
504 REGULATION OF MITOTIC CELL CYCLE 44 468 0.0002097 0.001936
505 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 9 40 0.000211 0.00194
506 DEVELOPMENTAL PIGMENTATION 9 40 0.000211 0.00194
507 MEMORY 15 98 0.0002147 0.001961
508 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 15 98 0.0002147 0.001961
509 RETINA DEVELOPMENT IN CAMERA TYPE EYE 18 131 0.000215 0.001961
510 RESPONSE TO STARVATION 20 154 0.0002141 0.001961
511 EMBRYONIC FORELIMB MORPHOGENESIS 8 32 0.0002175 0.001977
512 METANEPHRIC NEPHRON DEVELOPMENT 8 32 0.0002175 0.001977
513 CARDIAC CELL DEVELOPMENT 10 49 0.0002243 0.002035
514 REGULATION OF CELL JUNCTION ASSEMBLY 12 68 0.0002339 0.002117
515 REGULATION OF PROTEIN KINASE B SIGNALING 17 121 0.0002434 0.002199
516 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 6 18 0.0002461 0.002215
517 OSTEOBLAST DEVELOPMENT 6 18 0.0002461 0.002215
518 REGULATION OF PROTEIN TARGETING 32 307 0.000249 0.002236
519 CARDIAC LEFT VENTRICLE MORPHOGENESIS 5 12 0.0002507 0.00224
520 RESPONSE TO PROSTAGLANDIN E 7 25 0.0002525 0.00224
521 LUNG CELL DIFFERENTIATION 7 25 0.0002525 0.00224
522 CARTILAGE MORPHOGENESIS 5 12 0.0002507 0.00224
523 MEMBRANE ASSEMBLY 7 25 0.0002525 0.00224
524 REGULATION OF INFLAMMATORY RESPONSE 31 294 0.0002523 0.00224
525 PROTEIN AUTOPHOSPHORYLATION 23 192 0.0002527 0.00224
526 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 20 156 0.0002549 0.002255
527 REGULATION OF MEMBRANE DEPOLARIZATION 9 41 0.0002577 0.002267
528 POST EMBRYONIC DEVELOPMENT 14 89 0.0002578 0.002267
529 LUNG ALVEOLUS DEVELOPMENT 9 41 0.0002577 0.002267
530 RESPONSE TO IONIZING RADIATION 19 145 0.0002716 0.002384
531 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 16 111 0.0002726 0.002388
532 REGULATION OF CELL MATRIX ADHESION 14 90 0.0002905 0.002541
533 MULTICELLULAR ORGANISM REPRODUCTION 64 768 0.000293 0.002558
534 REGULATION OF GLUCOSE IMPORT 11 60 0.0002988 0.002599
535 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 11 60 0.0002988 0.002599
536 REGULATION OF EXTENT OF CELL GROWTH 15 101 0.0003011 0.002614
537 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 12 70 0.0003097 0.002684
538 ARTERY MORPHOGENESIS 10 51 0.0003166 0.002733
539 CELLULAR RESPONSE TO FATTY ACID 10 51 0.0003166 0.002733
540 REGULATION OF METAL ION TRANSPORT 33 325 0.0003244 0.002796
541 REGULATION OF MESENCHYMAL CELL PROLIFERATION 8 34 0.0003414 0.002936
542 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 6 19 0.0003434 0.002948
543 POSITIVE REGULATION OF STEM CELL PROLIFERATION 11 61 0.0003472 0.002975
544 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 37 381 0.0003505 0.002998
545 ENDODERM DEVELOPMENT 12 71 0.0003548 0.003024
546 LYMPHOCYTE DIFFERENTIATION 24 209 0.0003542 0.003024
547 CELLULAR RESPONSE TO IONIZING RADIATION 10 52 0.0003734 0.003176
548 CELLULAR RESPONSE TO RADIATION 18 137 0.0003766 0.003198
549 REGULATION OF CHOLESTEROL STORAGE 5 13 0.0003895 0.003301
550 INTEGRIN MEDIATED SIGNALING PATHWAY 13 82 0.0003915 0.003312
551 REGULATION OF TRANSPORTER ACTIVITY 23 198 0.0003951 0.003336
552 REGULATION OF WOUND HEALING 17 126 0.000396 0.003338
553 CELLULAR CATABOLIC PROCESS 99 1322 0.0003978 0.003347
554 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 11 62 0.000402 0.003376
555 RESPONSE TO CALCIUM ION 16 115 0.0004099 0.003437
556 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 14 93 0.0004108 0.003438
557 NEGATIVE REGULATION OF CELL CELL ADHESION 18 138 0.0004119 0.003441
558 REGULATION OF GTPASE ACTIVITY 57 673 0.0004156 0.003461
559 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 15 104 0.0004158 0.003461
560 CELL CHEMOTAXIS 20 162 0.0004208 0.003491
561 CELLULAR RESPONSE TO ABIOTIC STIMULUS 28 263 0.0004209 0.003491
562 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 23 199 0.0004246 0.00351
563 AXIS ELONGATION 7 27 0.0004247 0.00351
564 MAMMARY GLAND EPITHELIUM DEVELOPMENT 10 53 0.0004385 0.003617
565 RESPONSE TO ORGANOPHOSPHORUS 18 139 0.00045 0.003706
566 MYELOID CELL DEVELOPMENT 9 44 0.0004513 0.00371
567 RESPONSE TO FIBROBLAST GROWTH FACTOR 16 116 0.0004524 0.003712
568 POSITIVE REGULATION OF HEMOPOIESIS 20 163 0.0004561 0.003736
569 POSITIVE REGULATION OF PROTEIN BINDING 12 73 0.0004619 0.003777
570 REGULATION OF MUSCLE ADAPTATION 11 63 0.0004638 0.003786
571 REGULATION OF CELL CYCLE PROCESS 49 558 0.0004657 0.003795
572 METANEPHRIC EPITHELIUM DEVELOPMENT 6 20 0.0004685 0.003805
573 MEGAKARYOCYTE DIFFERENTIATION 6 20 0.0004685 0.003805
574 LEUKOCYTE DIFFERENTIATION 30 292 0.0004884 0.003959
575 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 19 152 0.0004962 0.004016
576 NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 13 84 0.0004976 0.00402
577 MAMMARY GLAND DEVELOPMENT 16 117 0.0004985 0.00402
578 CARDIAC VENTRICLE DEVELOPMENT 15 106 0.0005116 0.004111
579 FAT CELL DIFFERENTIATION 15 106 0.0005116 0.004111
580 CANONICAL WNT SIGNALING PATHWAY 14 95 0.0005127 0.004113
581 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 74 0.0005249 0.004204
582 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 9 45 0.0005377 0.004292
583 ENDOCHONDRAL BONE MORPHOGENESIS 9 45 0.0005377 0.004292
584 REGULATION OF NEUROBLAST PROLIFERATION 7 28 0.0005404 0.004298
585 REGULATION OF FATTY ACID OXIDATION 7 28 0.0005404 0.004298
586 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 16 118 0.0005487 0.004357
587 MAINTENANCE OF LOCATION IN CELL 14 96 0.0005712 0.004528
588 MACROMOLECULE CATABOLIC PROCESS 73 926 0.0005737 0.00454
589 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 5 14 0.0005793 0.004561
590 METANEPHRIC MESENCHYME DEVELOPMENT 5 14 0.0005793 0.004561
591 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 5 14 0.0005793 0.004561
592 PLATELET ACTIVATION 18 142 0.0005832 0.004584
593 ARTERY DEVELOPMENT 12 75 0.000595 0.004661
594 NEURAL CREST CELL DIFFERENTIATION 12 75 0.000595 0.004661
595 CRANIAL SKELETAL SYSTEM DEVELOPMENT 10 55 0.000597 0.004669
596 B CELL HOMEOSTASIS 6 21 0.0006264 0.004849
597 CORONARY VASCULATURE DEVELOPMENT 8 37 0.0006295 0.004849
598 CHONDROCYTE DEVELOPMENT 6 21 0.0006264 0.004849
599 POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 6 21 0.0006264 0.004849
600 MYOBLAST DIFFERENTIATION 8 37 0.0006295 0.004849
601 LEARNING 17 131 0.0006251 0.004849
602 REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS 6 21 0.0006264 0.004849
603 PROTEIN STABILIZATION 17 131 0.0006251 0.004849
604 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 8 37 0.0006295 0.004849
605 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 9 46 0.0006372 0.004901
606 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 24 218 0.0006546 0.005026
607 HEMOSTASIS 31 311 0.0006628 0.00508
608 ESTABLISHMENT OF PROTEIN LOCALIZATION 104 1423 0.0006681 0.005113
609 REGULATION OF CALCIUM MEDIATED SIGNALING 12 76 0.0006728 0.00514
610 EPIDERMIS MORPHOGENESIS 7 29 0.0006798 0.005177
611 PIGMENT CELL DIFFERENTIATION 7 29 0.0006798 0.005177
612 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 11 66 0.0006989 0.00529
613 CYTOKINE MEDIATED SIGNALING PATHWAY 41 452 0.0006992 0.00529
614 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 11 66 0.0006989 0.00529
615 REGULATION OF CARDIAC MUSCLE CONTRACTION 11 66 0.0006989 0.00529
616 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 14 98 0.0007054 0.005329
617 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 34 354 0.000726 0.005475
618 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 12 77 0.0007589 0.005714
619 PROTEIN COMPLEX SUBUNIT ORGANIZATION 110 1527 0.0007815 0.005874
620 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 23 208 0.0007901 0.00593
621 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 11 67 0.0007964 0.005968
622 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 28 274 0.0008051 0.006023
623 POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION 6 22 0.0008227 0.006144
624 REGULATION OF MEMBRANE POTENTIAL 33 343 0.0008376 0.006246
625 MEMBRANE BIOGENESIS 7 30 0.0008461 0.006249
626 BLASTOCYST FORMATION 7 30 0.0008461 0.006249
627 NEGATIVE REGULATION OF CELL MATRIX ADHESION 7 30 0.0008461 0.006249
628 REGULATION OF CALCIUM ION TRANSPORT 23 209 0.000844 0.006249
629 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 23 209 0.000844 0.006249
630 ESTABLISHMENT OF ENDOTHELIAL BARRIER 7 30 0.0008461 0.006249
631 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 17 135 0.0008827 0.006499
632 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 9 48 0.0008814 0.006499
633 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 22 197 0.0008914 0.006552
634 REGULATION OF CELL SIZE 20 172 0.0009073 0.006659
635 PLATELET AGGREGATION 8 39 0.0009123 0.006685
636 PROTEOGLYCAN BIOSYNTHETIC PROCESS 10 58 0.0009212 0.00674
637 PEPTIDYL SERINE MODIFICATION 18 148 0.0009537 0.006967
638 DENDRITE DEVELOPMENT 12 79 0.0009588 0.006993
639 REGULATED EXOCYTOSIS 24 224 0.0009612 0.006999
640 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 34 360 0.0009726 0.007071
641 REGULATION OF CELLULAR KETONE METABOLIC PROCESS 20 173 0.0009756 0.007081
642 LIPID LOCALIZATION 27 264 0.000977 0.007081
643 CELL CELL ADHESION 51 608 0.001014 0.007335
644 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 9 49 0.001029 0.007424
645 CELLULAR RESPONSE TO CALCIUM ION 9 49 0.001029 0.007424
646 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 7 31 0.001043 0.007513
647 RENAL SYSTEM PROCESS 14 102 0.001055 0.007587
648 REGULATION OF METANEPHROS DEVELOPMENT 6 23 0.001063 0.007634
649 REGULATION OF VESICLE MEDIATED TRANSPORT 41 462 0.001069 0.007668
650 ENSHEATHMENT OF NEURONS 13 91 0.00108 0.007719
651 AXON ENSHEATHMENT 13 91 0.00108 0.007719
652 ENDODERMAL CELL DIFFERENTIATION 8 40 0.001088 0.007726
653 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 19 162 0.001087 0.007726
654 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 19 162 0.001087 0.007726
655 RESPONSE TO CADMIUM ION 8 40 0.001088 0.007726
656 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 40 448 0.001091 0.007738
657 OSTEOBLAST DIFFERENTIATION 16 126 0.001129 0.007996
658 MAINTENANCE OF LOCATION 17 138 0.001131 0.007996
659 EXTRACELLULAR MATRIX ASSEMBLY 5 16 0.001156 0.00811
660 CARDIAC MYOFIBRIL ASSEMBLY 5 16 0.001156 0.00811
661 MEGAKARYOCYTE DEVELOPMENT 5 16 0.001156 0.00811
662 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 5 16 0.001156 0.00811
663 REGULATION OF FATTY ACID BETA OXIDATION 5 16 0.001156 0.00811
664 REGULATION OF CALCIUM ION IMPORT 14 103 0.001162 0.008143
665 CELLULAR RESPONSE TO BIOTIC STIMULUS 19 163 0.00117 0.008185
666 PHOSPHOLIPID METABOLIC PROCESS 34 364 0.001175 0.008211
667 REGULATION OF ADHERENS JUNCTION ORGANIZATION 9 50 0.001196 0.008322
668 CELLULAR RESPONSE TO CAMP 9 50 0.001196 0.008322
669 ENDODERM FORMATION 9 50 0.001196 0.008322
670 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 24 228 0.001229 0.008532
671 CHEMICAL HOMEOSTASIS 68 874 0.001232 0.008542
672 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 7 32 0.001274 0.00877
673 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 7 32 0.001274 0.00877
674 PROXIMAL DISTAL PATTERN FORMATION 7 32 0.001274 0.00877
675 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 7 32 0.001274 0.00877
676 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 7 32 0.001274 0.00877
677 MULTI ORGANISM REPRODUCTIVE PROCESS 69 891 0.001283 0.008816
678 REGULATION OF LIPID STORAGE 8 41 0.001289 0.008845
679 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 11 71 0.001306 0.008939
680 SKIN EPIDERMIS DEVELOPMENT 11 71 0.001306 0.008939
681 CELL CYCLE PROCESS 81 1081 0.001308 0.00894
682 CELLULAR HOMEOSTASIS 55 676 0.001321 0.009013
683 HEPATICOBILIARY SYSTEM DEVELOPMENT 16 128 0.001337 0.009106
684 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 29 297 0.00134 0.009112
685 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 6 24 0.001354 0.009143
686 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 24 0.001354 0.009143
687 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 6 24 0.001354 0.009143
688 POSITIVE REGULATION OF CELL ACTIVATION 30 311 0.001353 0.009143
689 EXPLORATION BEHAVIOR 6 24 0.001354 0.009143
690 POSITIVE REGULATION OF CELL CELL ADHESION 25 243 0.00136 0.009168
691 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 10 61 0.001377 0.009276
692 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 9 51 0.001385 0.009286
693 REGULATION OF NEUROTRANSMITTER SECRETION 9 51 0.001385 0.009286
694 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 9 51 0.001385 0.009286
695 RESPONSE TO NUTRIENT 21 191 0.001405 0.009408
696 RHYTHMIC PROCESS 29 298 0.00141 0.009428
697 RESPONSE TO BACTERIUM 45 528 0.001429 0.009537
698 REGULATION OF RECEPTOR ACTIVITY 15 117 0.001443 0.009623
699 REGULATION OF REPRODUCTIVE PROCESS 16 129 0.001452 0.009665
700 REGULATION OF TRANSMEMBRANE TRANSPORT 38 426 0.001459 0.009696
701 ENERGY RESERVE METABOLIC PROCESS 11 72 0.001469 0.00975
702 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 44 514 0.001473 0.009761
703 ORGAN REGENERATION 12 83 0.001491 0.009828
704 HAIR CYCLE 12 83 0.001491 0.009828
705 PROTEOGLYCAN METABOLIC PROCESS 12 83 0.001491 0.009828
706 MOLTING CYCLE 12 83 0.001491 0.009828
707 NEURON PROJECTION GUIDANCE 22 205 0.001501 0.009881
708 POSITIVE REGULATION OF GLUCOSE TRANSPORT 8 42 0.001519 0.00998
NumGOOverlapSizeP ValueAdj. P Value
1 ENZYME BINDING 184 1737 4.12e-20 3.828e-17
2 KINASE BINDING 84 606 7.827e-16 3.636e-13
3 MACROMOLECULAR COMPLEX BINDING 142 1399 5.023e-14 1.555e-11
4 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 74 629 1.424e-10 3.307e-08
5 PROTEIN KINASE ACTIVITY 74 640 3.155e-10 5.861e-08
6 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 46 315 5.563e-10 6.6e-08
7 KINASE ACTIVITY 89 842 5.247e-10 6.6e-08
8 TRANSCRIPTION FACTOR BINDING 64 524 5.683e-10 6.6e-08
9 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 47 328 6.859e-10 7.08e-08
10 GLYCOSAMINOGLYCAN BINDING 35 205 1.006e-09 9.343e-08
11 IDENTICAL PROTEIN BINDING 114 1209 1.783e-09 1.506e-07
12 SMAD BINDING 19 72 4.642e-09 3.594e-07
13 GROWTH FACTOR BINDING 25 123 6.606e-09 4.721e-07
14 PROTEIN COMPLEX BINDING 92 935 9.822e-09 6.518e-07
15 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 96 992 1.058e-08 6.555e-07
16 ACTIN BINDING 50 393 1.177e-08 6.834e-07
17 REGULATORY REGION NUCLEIC ACID BINDING 83 818 1.372e-08 7.209e-07
18 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 35 226 1.397e-08 7.209e-07
19 RECEPTOR BINDING 129 1476 1.542e-08 7.539e-07
20 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 20 90 4.414e-08 2.05e-06
21 CHROMATIN BINDING 52 435 4.87e-08 2.154e-06
22 CYTOSKELETAL PROTEIN BINDING 80 819 1.287e-07 5.433e-06
23 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 18 81 2.071e-07 7.695e-06
24 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 106 1199 1.916e-07 7.695e-06
25 CELL ADHESION MOLECULE BINDING 29 186 2.065e-07 7.695e-06
26 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 62 588 2.615e-07 9.345e-06
27 SEQUENCE SPECIFIC DNA BINDING 94 1037 3.27e-07 1.125e-05
28 PROTEIN DIMERIZATION ACTIVITY 101 1149 4.969e-07 1.649e-05
29 HEPARIN BINDING 25 157 9.4e-07 3.011e-05
30 RIBONUCLEOTIDE BINDING 146 1860 1.204e-06 3.728e-05
31 ADENYL NUCLEOTIDE BINDING 123 1514 1.721e-06 5.157e-05
32 INTEGRIN BINDING 19 105 2.7e-06 7.838e-05
33 SULFUR COMPOUND BINDING 31 234 2.984e-06 8.4e-05
34 DOUBLE STRANDED DNA BINDING 71 764 4.021e-06 0.0001099
35 INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 7 15 5.418e-06 0.0001438
36 CYTOKINE BINDING 17 92 6.676e-06 0.0001709
37 COLLAGEN BINDING 14 65 6.808e-06 0.0001709
38 PROTEIN SERINE THREONINE KINASE ACTIVITY 47 445 6.996e-06 0.000171
39 ACTIVATING TRANSCRIPTION FACTOR BINDING 13 57 7.419e-06 0.0001767
40 PROTEIN TYROSINE KINASE ACTIVITY 25 176 7.774e-06 0.0001773
41 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 21 133 7.826e-06 0.0001773
42 PROTEIN DOMAIN SPECIFIC BINDING 60 624 8.05e-06 0.0001781
43 TRANSFORMING GROWTH FACTOR BETA BINDING 7 16 9.187e-06 0.0001985
44 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 29 228 1.364e-05 0.0002881
45 PROTEIN HOMODIMERIZATION ACTIVITY 66 722 1.495e-05 0.0003086
46 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 14 70 1.68e-05 0.0003393
47 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 12 53 1.796e-05 0.0003549
48 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 13 64 2.811e-05 0.000544
49 INSULIN RECEPTOR BINDING 9 32 3.184e-05 0.0006037
50 NITRIC OXIDE SYNTHASE BINDING 7 19 3.512e-05 0.0006474
51 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 17 104 3.554e-05 0.0006474
52 CORE PROMOTER PROXIMAL REGION DNA BINDING 39 371 4.589e-05 0.0008199
53 MOLECULAR FUNCTION REGULATOR 105 1353 6.859e-05 0.001202
54 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 6 15 7.621e-05 0.001311
55 CALMODULIN BINDING 23 179 8.786e-05 0.001484
56 TRANSCRIPTION COACTIVATOR ACTIVITY 32 296 0.0001276 0.002117
57 R SMAD BINDING 7 23 0.0001415 0.002306
58 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 14 86 0.0001779 0.002849
59 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 32 303 0.0001963 0.003091
60 PROLINE RICH REGION BINDING 6 19 0.0003434 0.005317
61 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 9 43 0.0003767 0.005737
62 S100 PROTEIN BINDING 5 13 0.0003895 0.005836
63 KINASE REGULATOR ACTIVITY 22 186 0.0004074 0.006007
64 MAGNESIUM ION BINDING 23 199 0.0004246 0.006163
65 UBIQUITIN LIKE PROTEIN LIGASE BINDING 28 264 0.0004474 0.006394
66 CORE PROMOTER BINDING 19 152 0.0004962 0.006985
67 PEPTIDE HORMONE BINDING 8 36 0.0005173 0.007173
68 BHLH TRANSCRIPTION FACTOR BINDING 7 28 0.0005404 0.007276
69 FIBRONECTIN BINDING 7 28 0.0005404 0.007276
70 HORMONE BINDING 11 65 0.0006115 0.008001
71 ENZYME REGULATOR ACTIVITY 75 959 0.0006083 0.008001
72 PROTEIN HETERODIMERIZATION ACTIVITY 42 468 0.00075 0.009677
NumGOOverlapSizeP ValueAdj. P Value
1 ANCHORING JUNCTION 66 489 3.74e-12 2.184e-09
2 CELL SUBSTRATE JUNCTION 57 398 1.056e-11 3.085e-09
3 EXTRACELLULAR MATRIX 56 426 4.564e-10 8.884e-08
4 ACTIN CYTOSKELETON 57 444 7.885e-10 9.21e-08
5 CELL LEADING EDGE 49 350 6.677e-10 9.21e-08
6 CELL SURFACE 80 757 4.145e-09 4.034e-07
7 CYTOPLASMIC REGION 41 287 9.198e-09 7.352e-07
8 PROTEINACEOUS EXTRACELLULAR MATRIX 47 356 1.007e-08 7.352e-07
9 NEURON PART 115 1265 1.204e-08 7.371e-07
10 CELL JUNCTION 107 1151 1.262e-08 7.371e-07
11 CELL CORTEX 36 238 1.637e-08 8.692e-07
12 CYTOSKELETON 161 1967 1.997e-08 9.718e-07
13 CELL PROJECTION 147 1786 6.516e-08 2.927e-06
14 INTRACELLULAR VESICLE 108 1259 6.384e-07 2.663e-05
15 RUFFLE 25 156 8.319e-07 3.239e-05
16 SOMATODENDRITIC COMPARTMENT 65 650 8.908e-07 3.251e-05
17 CELL CORTEX PART 21 119 1.253e-06 4.065e-05
18 SITE OF POLARIZED GROWTH 24 149 1.249e-06 4.065e-05
19 NEURON PROJECTION 85 942 1.48e-06 4.549e-05
20 TRANSCRIPTION FACTOR COMPLEX 37 298 1.676e-06 4.895e-05
21 CYTOSKELETAL PART 117 1436 2.75e-06 7.408e-05
22 MEMBRANE REGION 97 1134 2.791e-06 7.408e-05
23 CORTICAL ACTIN CYTOSKELETON 13 58 9.098e-06 0.000231
24 GOLGI APPARATUS 115 1445 9.978e-06 0.0002428
25 EXTRACELLULAR MATRIX COMPONENT 20 125 1.044e-05 0.0002438
26 LAMELLIPODIUM 24 172 1.592e-05 0.0003575
27 SYNAPSE 68 754 1.722e-05 0.0003592
28 ACTIN FILAMENT 14 70 1.68e-05 0.0003592
29 CELL PROJECTION PART 81 946 1.838e-05 0.00037
30 CORTICAL CYTOSKELETON 15 81 2.237e-05 0.0004355
31 SIDE OF MEMBRANE 43 428 5.585e-05 0.001052
32 PERINUCLEAR REGION OF CYTOPLASM 58 642 6.775e-05 0.001236
33 SECRETORY VESICLE 45 461 7.526e-05 0.001332
34 CELL DIVISION SITE 11 52 7.791e-05 0.001338
35 MYELIN SHEATH 22 168 9.349e-05 0.00156
36 CELL BODY 47 494 9.767e-05 0.001584
37 BASEMENT MEMBRANE 15 93 0.0001178 0.001859
38 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 8 30 0.0001331 0.002046
39 AXON 41 418 0.0001393 0.002085
40 PLASMA MEMBRANE REGION 76 929 0.0001455 0.002124
41 VESICLE LUMEN 16 106 0.0001582 0.002254
42 CONTRACTILE FIBER 25 211 0.0001654 0.0023
43 PML BODY 15 97 0.0001911 0.002596
44 CYTOPLASMIC VESICLE PART 53 601 0.0002508 0.003329
45 CYTOPLASMIC SIDE OF MEMBRANE 21 170 0.0003032 0.003934
46 DENDRITE 42 451 0.0003532 0.004484
47 MEMBRANE MICRODOMAIN 30 288 0.0003874 0.004814
48 ACTOMYOSIN 11 62 0.000402 0.00489
49 FILOPODIUM 14 94 0.0004593 0.005365
50 EXTRACELLULAR SPACE 102 1376 0.000464 0.005365
51 FILAMENTOUS ACTIN 6 20 0.0004685 0.005365
52 EXTRINSIC COMPONENT OF MEMBRANE 27 252 0.0004787 0.005376
53 NEUROMUSCULAR JUNCTION 10 54 0.0005127 0.005649
54 PLATELET ALPHA GRANULE 12 75 0.000595 0.006435
55 SECRETORY GRANULE 34 352 0.000657 0.006976
56 RECEPTOR COMPLEX 32 327 0.0007493 0.007814
57 CELL CELL JUNCTION 36 383 0.0007645 0.007832
58 ACTIN FILAMENT BUNDLE 10 57 0.0008002 0.008028
59 LEADING EDGE MEMBRANE 17 134 0.000811 0.008028
60 INTRINSIC COMPONENT OF PLASMA MEMBRANE 117 1649 0.0009248 0.009001
61 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 17 136 0.0009596 0.009187

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 PI3K_Akt_signaling_pathway_hsa04151 54 352 2.46e-12 1.279e-10
2 Focal_adhesion_hsa04510 38 199 6.092e-12 1.584e-10
3 MAPK_signaling_pathway_hsa04010 42 295 6.724e-09 1.166e-07
4 Regulation_of_actin_cytoskeleton_hsa04810 33 208 1.971e-08 2.563e-07
5 Rap1_signaling_pathway_hsa04015 31 206 1.8e-07 1.872e-06
6 Apelin_signaling_pathway_hsa04371 24 137 2.564e-07 2.222e-06
7 ECM_receptor_interaction_hsa04512 17 82 1.272e-06 9.448e-06
8 AMPK_signaling_pathway_hsa04152 21 121 1.66e-06 9.832e-06
9 Jak_STAT_signaling_pathway_hsa04630 25 162 1.702e-06 9.832e-06
10 Hippo_signaling_pathway_hsa04390 24 154 2.284e-06 1.188e-05
11 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 22 139 4.605e-06 2.16e-05
12 Adherens_junction_hsa04520 15 72 4.984e-06 2.16e-05
13 Ras_signaling_pathway_hsa04014 29 232 1.903e-05 7.612e-05
14 FoxO_signaling_pathway_hsa04068 19 132 7.728e-05 0.000287
15 TGF_beta_signaling_pathway_hsa04350 14 84 0.0001374 0.0004763
16 cGMP_PKG_signaling_pathway_hsa04022 20 163 0.0004561 0.001482
17 Cytokine_cytokine_receptor_interaction_hsa04060 28 270 0.0006397 0.001957
18 Tight_junction_hsa04530 20 170 0.000783 0.002224
19 Wnt_signaling_pathway_hsa04310 18 146 0.0008126 0.002224
20 HIF_1_signaling_pathway_hsa04066 14 100 0.0008654 0.00225
21 Cell_adhesion_molecules_.CAMs._hsa04514 17 145 0.001948 0.004823
22 Cellular_senescence_hsa04218 18 160 0.002316 0.005475
23 Calcium_signaling_pathway_hsa04020 19 182 0.004133 0.009345
24 Phagosome_hsa04145 16 152 0.007473 0.01619
25 p53_signaling_pathway_hsa04115 9 68 0.01 0.02081
26 Sphingolipid_signaling_pathway_hsa04071 13 118 0.01047 0.02094
27 Hedgehog_signaling_pathway_hsa04340 7 47 0.01188 0.02289
28 Cell_cycle_hsa04110 13 124 0.01544 0.02867
29 Phosphatidylinositol_signaling_system_hsa04070 11 99 0.01668 0.0299
30 Gap_junction_hsa04540 10 88 0.01896 0.03287
31 cAMP_signaling_pathway_hsa04024 18 198 0.01983 0.03326
32 Phospholipase_D_signaling_pathway_hsa04072 14 146 0.02481 0.04032
33 TNF_signaling_pathway_hsa04668 11 108 0.02973 0.04684
34 Oocyte_meiosis_hsa04114 12 124 0.0338 0.05169
35 ErbB_signaling_pathway_hsa04012 9 85 0.03767 0.05595
36 Endocytosis_hsa04144 20 244 0.03873 0.05595
37 Ferroptosis_hsa04216 5 40 0.0607 0.08531
38 Hippo_signaling_pathway_multiple_species_hsa04392 4 29 0.06682 0.09144
39 ABC_transporters_hsa02010 5 45 0.091 0.1213
40 mTOR_signaling_pathway_hsa04150 12 151 0.1108 0.1441
41 Autophagy_animal_hsa04140 10 128 0.1479 0.1876
42 Notch_signaling_pathway_hsa04330 4 48 0.2543 0.3148
43 Mitophagy_animal_hsa04137 5 65 0.2673 0.3233
44 Necroptosis_hsa04217 10 164 0.3818 0.4492
45 VEGF_signaling_pathway_hsa04370 4 59 0.3887 0.4492
46 NF_kappa_B_signaling_pathway_hsa04064 6 95 0.3989 0.4509
47 Apoptosis_hsa04210 7 138 0.6117 0.6767
48 Neuroactive_ligand_receptor_interaction_hsa04080 11 278 0.8836 0.9183
49 Lysosome_hsa04142 4 123 0.9007 0.9183

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MIR143HG

 hsa-miR-107;hsa-miR-129-5p;hsa-miR-142-3p;hsa-miR-193b-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-34c-5p;hsa-miR-429;hsa-miR-486-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-9-5p 12 MYLK Sponge network -4.237 0 -3.918 0 0.867
2

RP11-166D19.1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 14 RECK Sponge network -3.855 0 -2.386 0 0.779
3

HAND2-AS1

 hsa-miR-107;hsa-miR-129-5p;hsa-miR-142-3p;hsa-miR-193b-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-34c-5p;hsa-miR-429;hsa-miR-486-5p;hsa-miR-590-3p;hsa-miR-9-5p 11 MYLK Sponge network -5.605 0 -3.918 0 0.748
4

MAGI2-AS3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-455-5p;hsa-miR-590-3p 15 RECK Sponge network -2.414 0 -2.386 0 0.743
5

RP11-166D19.1

 hsa-let-7b-5p;hsa-miR-129-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-421;hsa-miR-429;hsa-miR-491-5p;hsa-miR-590-3p;hsa-miR-590-5p 12 PDGFRA Sponge network -3.855 0 -2.376 0 0.728
6

ADAMTS9-AS1

 hsa-miR-107;hsa-miR-129-5p;hsa-miR-142-3p;hsa-miR-193b-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-34c-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 10 MYLK Sponge network -7.614 0 -3.918 0 0.711
7

RP11-1024P17.1

 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p 11 TGFBR2 Sponge network -1.552 0 -1.561 0 0.699
8

DNM3OS

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 11 RECK Sponge network -2.298 1.0E-5 -2.386 0 0.685
9

ADAMTS9-AS1

 hsa-let-7e-5p;hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-16-5p;hsa-miR-324-5p;hsa-miR-342-3p;hsa-miR-361-5p;hsa-miR-421 10 RUNX1T1 Sponge network -7.614 0 -3.291 0 0.672
10

MAGI2-AS3

 hsa-let-7b-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-491-5p;hsa-miR-590-3p 11 PDGFRA Sponge network -2.414 0 -2.376 0 0.669
11

MIR143HG

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-429;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 15 RECK Sponge network -4.237 0 -2.386 0 0.668
12

GAS6-AS2

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-421;hsa-miR-429;hsa-miR-590-5p 11 RECK Sponge network -2.655 0 -2.386 0 0.651
13

FENDRR

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-129-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-34a-5p;hsa-miR-34c-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-590-3p 12 PDGFRA Sponge network -4.793 0 -2.376 0 0.643
14

MIR143HG

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 12 DMD Sponge network -4.237 0 -3.694 0 0.633
15

LINC00702

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-421;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 15 RECK Sponge network -2.704 0 -2.386 0 0.629
16

HAND2-AS1

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-129-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-34c-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-491-5p;hsa-miR-590-3p 15 PDGFRA Sponge network -5.605 0 -2.376 0 0.625
17

HAND2-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-455-5p;hsa-miR-590-3p 15 RECK Sponge network -5.605 0 -2.386 0 0.624
18

RP11-175K6.1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-421;hsa-miR-590-5p 12 RECK Sponge network -2.386 0 -2.386 0 0.608
19

HAND2-AS1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-375;hsa-miR-429;hsa-miR-590-3p 14 DMD Sponge network -5.605 0 -3.694 0 0.596
20

MAGI2-AS3

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-375;hsa-miR-429;hsa-miR-590-3p 13 DMD Sponge network -2.414 0 -3.694 0 0.587
21

ADAMTS9-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 17 RECK Sponge network -7.614 0 -2.386 0 0.585
22

RP11-166D19.1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 12 DMD Sponge network -3.855 0 -3.694 0 0.584
23

MIR143HG

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-129-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-34c-5p;hsa-miR-429;hsa-miR-491-5p;hsa-miR-590-3p;hsa-miR-590-5p 14 PDGFRA Sponge network -4.237 0 -2.376 0 0.581
24

ADAMTS9-AS1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-375;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 15 DMD Sponge network -7.614 0 -3.694 0 0.569
25

MEG3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-421;hsa-miR-429;hsa-miR-590-5p 11 RECK Sponge network -2.367 0 -2.386 0 0.558
26

LINC00702

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 DMD Sponge network -2.704 0 -3.694 0 0.551
27

RP11-243M5.1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-455-5p;hsa-miR-590-5p 10 RECK Sponge network -8.824 0 -2.386 0 0.542
28 RASSF8-AS1 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-429;hsa-miR-590-3p 10 RECK Sponge network -0.877 0.00508 -2.386 0 0.539
29

NR2F1-AS1

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-421;hsa-miR-429;hsa-miR-491-5p;hsa-miR-590-3p 12 PDGFRA Sponge network -1.881 0 -2.376 0 0.536
30

LINC00654

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p 13 DMD Sponge network -1.448 0.00044 -3.694 0 0.531
31

ADAMTS9-AS1

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-129-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-34c-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-491-5p;hsa-miR-590-3p;hsa-miR-590-5p 16 PDGFRA Sponge network -7.614 0 -2.376 0 0.527
32

ADAMTS9-AS1

 hsa-miR-107;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-342-3p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 10 SVEP1 Sponge network -7.614 0 -3.273 0 0.523
33

C20orf166-AS1

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-491-5p 10 PDGFRA Sponge network -6.333 0 -2.376 0 0.523
34

NR2F1-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p 12 RECK Sponge network -1.881 0 -2.386 0 0.522
35

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 15 TGFBR2 Sponge network -2.414 0 -1.561 0 0.515
36

PDZRN3-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p 13 RECK Sponge network -5.049 1.0E-5 -2.386 0 0.514
37

LINC00702

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-129-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-491-5p;hsa-miR-590-3p;hsa-miR-590-5p 14 PDGFRA Sponge network -2.704 0 -2.376 0 0.512
38

LINC00654

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p 12 RECK Sponge network -1.448 0.00044 -2.386 0 0.512
39 RP11-389C8.2 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -0.61 0.01261 -1.561 0 0.498
40

RP11-805I24.3

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-34a-5p;hsa-miR-34c-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-491-5p 11 PDGFRA Sponge network -5.815 0 -2.376 0 0.494
41

ZFHX4-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 10 RECK Sponge network -2.966 0.00743 -2.386 0 0.488
42

LINC00473

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p 10 RECK Sponge network -5.53 0 -2.386 0 0.488
43

AC011526.1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-421;hsa-miR-590-3p 10 RECK Sponge network -1.209 1.0E-5 -2.386 0 0.483
44

LINC00327

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-455-5p;hsa-miR-590-3p 10 RECK Sponge network -1.951 0.01135 -2.386 0 0.481
45

MIR143HG

 hsa-miR-107;hsa-miR-125a-3p;hsa-miR-200c-3p;hsa-miR-326;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-342-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 11 NTRK2 Sponge network -4.237 0 -3.444 0 0.481
46

RP11-531A24.5

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p 10 DMD Sponge network -1.752 0 -3.694 0 0.481
47 RP11-554A11.4 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-421 10 RECK Sponge network -3.989 0 -2.386 0 0.479
48

MAGI2-AS3

 hsa-miR-107;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-877-5p 10 LEPR Sponge network -2.414 0 -2.127 0 0.474
49

MIR143HG

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 16 TGFBR2 Sponge network -4.237 0 -1.561 0 0.47
50

C20orf166-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-429;hsa-miR-455-5p 13 RECK Sponge network -6.333 0 -2.386 0 0.468
51

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p 15 TGFBR2 Sponge network -3.855 0 -1.561 0 0.465
52

ADAMTS9-AS1

 hsa-miR-107;hsa-miR-125a-3p;hsa-miR-200c-3p;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-342-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 11 NTRK2 Sponge network -7.614 0 -3.444 0 0.46
53

RP11-389G6.3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-590-3p 11 RECK Sponge network -7.573 0 -2.386 0 0.456
54

RP11-81H14.2

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-421;hsa-miR-429 10 RECK Sponge network -2.322 0.00014 -2.386 0 0.454
55

RP11-175K6.1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-5p;hsa-miR-93-5p 13 TGFBR2 Sponge network -2.386 0 -1.561 0 0.451
56

C20orf166-AS1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-362-3p;hsa-miR-375;hsa-miR-429 10 DMD Sponge network -6.333 0 -3.694 0 0.45
57

LINC00702

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 15 TGFBR2 Sponge network -2.704 0 -1.561 0 0.448
58

PDZRN3-AS1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 DMD Sponge network -5.049 1.0E-5 -3.694 0 0.443
59

LINC00702

 hsa-miR-107;hsa-miR-125a-3p;hsa-miR-200c-3p;hsa-miR-326;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-342-3p;hsa-miR-361-5p;hsa-miR-590-3p;hsa-miR-590-5p 10 NTRK2 Sponge network -2.704 0 -3.444 0 0.442
60 RP11-517P14.2 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -0.825 0.01106 -1.561 0 0.439
61

FENDRR

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-421;hsa-miR-455-5p;hsa-miR-590-3p 14 RECK Sponge network -4.793 0 -2.386 0 0.434
62

MAGI2-AS3

 hsa-miR-128-3p;hsa-miR-1296-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-98-5p 10 LIFR Sponge network -2.414 0 -2.633 0 0.431
63 CTD-2013N24.2 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-590-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -1.002 1.0E-5 -1.561 0 0.43
64

TP73-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429 12 RECK Sponge network -1.97 0 -2.386 0 0.423
65

MIR143HG

 hsa-miR-107;hsa-miR-320a;hsa-miR-320b;hsa-miR-326;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-342-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-877-5p 11 LEPR Sponge network -4.237 0 -2.127 0 0.422
66

FENDRR

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -4.793 0 -1.561 0 0.422
67

FENDRR

 hsa-miR-125a-3p;hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-421;hsa-miR-590-3p 10 KIT Sponge network -4.793 0 -2.522 0 0.421
68

RP11-456K23.1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 11 DMD Sponge network -1.962 1.0E-5 -3.694 0 0.421
69

BZRAP1-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-335-5p;hsa-miR-455-5p 10 RECK Sponge network -2.343 0 -2.386 0 0.42
70

FENDRR

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-590-3p 12 DMD Sponge network -4.793 0 -3.694 0 0.417
71

RP11-456K23.1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-429;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 15 RECK Sponge network -1.962 1.0E-5 -2.386 0 0.417
72

RP4-798P15.3

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-590-5p 11 TGFBR2 Sponge network -0.958 0.06952 -1.561 0 0.415
73 RP1-151F17.2 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p 14 TGFBR2 Sponge network -1.606 0 -1.561 0 0.414
74

AF131217.1

 hsa-miR-107;hsa-miR-146b-5p;hsa-miR-320b;hsa-miR-326;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-342-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-877-5p 11 LEPR Sponge network -5.31 0 -2.127 0 0.412
75

RP11-243M5.1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-5p 10 TGFBR2 Sponge network -8.824 0 -1.561 0 0.408
76

NR2F1-AS1

 hsa-miR-107;hsa-miR-125a-3p;hsa-miR-200c-3p;hsa-miR-326;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-342-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-590-3p 10 NTRK2 Sponge network -1.881 0 -3.444 0 0.406
77

ADAMTS9-AS1

 hsa-miR-128-3p;hsa-miR-1296-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-98-5p 10 LIFR Sponge network -7.614 0 -2.633 0 0.405
78

RP11-166D19.1

 hsa-miR-107;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-877-5p 10 LEPR Sponge network -3.855 0 -2.127 0 0.403
79 RP11-1008C21.2 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320b;hsa-miR-92a-3p;hsa-miR-93-5p 11 TGFBR2 Sponge network -0.999 0.0012 -1.561 0 0.402
80

ADAMTS9-AS1

 hsa-miR-107;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-342-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-877-5p 12 LEPR Sponge network -7.614 0 -2.127 0 0.399
81

PDZRN3-AS1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-590-5p 13 TGFBR2 Sponge network -5.049 1.0E-5 -1.561 0 0.398
82

LINC00702

 hsa-miR-107;hsa-miR-320a;hsa-miR-320b;hsa-miR-326;hsa-miR-330-5p;hsa-miR-342-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-877-5p 11 LEPR Sponge network -2.704 0 -2.127 0 0.398
83

RP11-887P2.5

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-421;hsa-miR-590-5p 10 RECK Sponge network -6.751 0 -2.386 0 0.397
84

AF131217.1

 hsa-miR-125a-3p;hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-222-3p;hsa-miR-338-3p;hsa-miR-342-3p;hsa-miR-421;hsa-miR-590-3p 11 KIT Sponge network -5.31 0 -2.522 0 0.394
85

RP11-531A24.5

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b 10 RECK Sponge network -1.752 0 -2.386 0 0.393
86

RP11-359B12.2

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 10 RECK Sponge network -1.336 0 -2.386 0 0.393
87

NR2F1-AS1

 hsa-miR-107;hsa-miR-320a;hsa-miR-320b;hsa-miR-326;hsa-miR-330-5p;hsa-miR-342-3p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-877-5p 10 LEPR Sponge network -1.881 0 -2.127 0 0.393
88 CTD-2589M5.4 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-5p 10 RECK Sponge network -7.181 0 -2.386 0 0.392
89

MIR22HG

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320b;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -1.994 0 -1.561 0 0.39
90

BZRAP1-AS1

 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-335-5p;hsa-miR-93-5p 10 TGFBR2 Sponge network -2.343 0 -1.561 0 0.387
91

AC093627.10

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-421;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 11 RECK Sponge network -2.338 8.0E-5 -2.386 0 0.385
92

TP73-AS1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-362-3p;hsa-miR-429 10 DMD Sponge network -1.97 0 -3.694 0 0.383
93

AF131217.1

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-362-3p;hsa-miR-375;hsa-miR-590-3p 10 DMD Sponge network -5.31 0 -3.694 0 0.382
94

RP11-356J5.12

 hsa-miR-107;hsa-miR-125a-3p;hsa-miR-200c-3p;hsa-miR-326;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-361-5p;hsa-miR-590-3p;hsa-miR-590-5p 10 NTRK2 Sponge network -2.015 0 -3.444 0 0.381
95

ZNF667-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-5p 10 RECK Sponge network -1.846 0.00013 -2.386 0 0.381
96 RP11-284N8.3 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-5p;hsa-miR-93-5p 12 TGFBR2 Sponge network -1.414 0.007 -1.561 0 0.38
97

MEG3

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-590-5p 10 DMD Sponge network -2.367 0 -3.694 0 0.38
98

NR2F1-AS1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -1.881 0 -1.561 0 0.374
99

GAS6-AS2

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-5p;hsa-miR-92a-3p 11 TGFBR2 Sponge network -2.655 0 -1.561 0 0.373
100 ACTA2-AS1 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-3p 10 TGFBR2 Sponge network -3.838 0 -1.561 0 0.372
101

MIR497HG

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-362-3p;hsa-miR-375;hsa-miR-590-5p 10 DMD Sponge network -3.802 0 -3.694 0 0.371
102

ADAMTS9-AS1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 16 TGFBR2 Sponge network -7.614 0 -1.561 0 0.368
103

ADAMTS9-AS1

 hsa-miR-125a-3p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-342-3p;hsa-miR-421;hsa-miR-590-3p 10 KIT Sponge network -7.614 0 -2.522 0 0.357
104

AC011526.1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-20a-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -1.209 1.0E-5 -1.561 0 0.357
105

HAND2-AS1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 14 TGFBR2 Sponge network -5.605 0 -1.561 0 0.353
106

RP11-887P2.5

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-5p;hsa-miR-93-5p 11 TGFBR2 Sponge network -6.751 0 -1.561 0 0.353
107

HCG11

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -1.194 0.00331 -1.561 0 0.352
108

LINC00865

 hsa-miR-125a-3p;hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-338-3p;hsa-miR-342-3p 10 KIT Sponge network -2.379 0 -2.522 0 0.35
109

LINC00654

 hsa-let-7b-5p;hsa-miR-26b-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-491-5p;hsa-miR-590-3p 11 PDGFRA Sponge network -1.448 0.00044 -2.376 0 0.349
110

LINC00473

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-31-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-590-3p 11 DMD Sponge network -5.53 0 -3.694 0 0.345
111

MIR143HG

 hsa-miR-128-3p;hsa-miR-1296-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-98-5p 10 LIFR Sponge network -4.237 0 -2.633 0 0.342
112

MIR497HG

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-5p;hsa-miR-93-5p 11 TGFBR2 Sponge network -3.802 0 -1.561 0 0.336
113

USP3-AS1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-421;hsa-miR-455-5p 12 RECK Sponge network -1.454 0 -2.386 0 0.334
114 PCED1B-AS1 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-92a-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -0.575 0.17488 -1.561 0 0.328
115

RP11-356J5.12

 hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-324-5p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 DMD Sponge network -2.015 0 -3.694 0 0.328
116 RP11-514D23.3 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-590-5p;hsa-miR-93-5p 10 TGFBR2 Sponge network -3.847 0 -1.561 0 0.325
117

DNM3OS

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 13 TGFBR2 Sponge network -2.298 1.0E-5 -1.561 0 0.323
118

AF131217.1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -5.31 0 -1.561 0 0.322
119

RP11-6O2.3

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-5p 13 TGFBR2 Sponge network -4.533 0 -1.561 0 0.321
120

C20orf166-AS1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-93-5p 12 TGFBR2 Sponge network -6.333 0 -1.561 0 0.32
121

LINC00641

 hsa-let-7b-5p;hsa-miR-107;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p 10 DMD Sponge network -1.851 0 -3.694 0 0.32
122 LINC00963 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p 11 TGFBR2 Sponge network -0.723 3.0E-5 -1.561 0 0.32
123

SNHG14

 hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-342-3p;hsa-miR-421;hsa-miR-590-3p 10 KIT Sponge network -2.055 0 -2.522 0 0.318
124

RP11-531A24.5

 hsa-miR-125a-3p;hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-338-3p;hsa-miR-342-3p 10 KIT Sponge network -1.752 0 -2.522 0 0.318
125

LINC00641

 hsa-miR-125a-3p;hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-342-3p;hsa-miR-590-3p 10 KIT Sponge network -1.851 0 -2.522 0 0.315
126 RP11-693J15.4 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-5p 11 TGFBR2 Sponge network -3.319 0.00281 -1.561 0 0.314
127

AF131217.1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-590-3p 13 RECK Sponge network -5.31 0 -2.386 0 0.314
128

LINC00473

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-5p 14 TGFBR2 Sponge network -5.53 0 -1.561 0 0.313
129

RP11-890B15.3

 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -1.019 0 -1.561 0 0.309
130

PWAR6

 hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-342-3p;hsa-miR-421;hsa-miR-590-3p 10 KIT Sponge network -2.542 0 -2.522 0 0.306
131

RP11-805I24.3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-362-3p;hsa-miR-421;hsa-miR-429;hsa-miR-455-5p 14 RECK Sponge network -5.815 0 -2.386 0 0.302
132

RP11-356J5.12

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-125a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p 14 RECK Sponge network -2.015 0 -2.386 0 0.299
133 RP11-967K21.1 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-335-5p;hsa-miR-92a-3p;hsa-miR-93-5p 11 TGFBR2 Sponge network -1.206 0.01654 -1.561 0 0.295
134 RP11-798M19.6 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-590-5p 10 RECK Sponge network -1.113 0 -2.386 0 0.292
135

RP11-6O2.3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-5p 11 RECK Sponge network -4.533 0 -2.386 0 0.291
136

USP3-AS1

 hsa-miR-125a-3p;hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-342-3p;hsa-miR-421 10 KIT Sponge network -1.454 0 -2.522 0 0.287
137

WDFY3-AS2

 hsa-miR-103a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 10 RECK Sponge network -1.607 0 -2.386 0 0.285
138

RP11-805I24.3

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-93-5p 12 TGFBR2 Sponge network -5.815 0 -1.561 0 0.283
139

RP11-1024P17.1

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-429;hsa-miR-590-3p 11 RECK Sponge network -1.552 0 -2.386 0 0.282
140

RP11-359B12.2

 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-590-3p;hsa-miR-590-5p 10 TGFBR2 Sponge network -1.336 0 -1.561 0 0.28
141

TP73-AS1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-92a-3p;hsa-miR-93-5p 13 TGFBR2 Sponge network -1.97 0 -1.561 0 0.28
142 A2M-AS1 hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-93-5p 11 TGFBR2 Sponge network -1.953 0.00771 -1.561 0 0.274
143 RP11-1223D19.1 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-590-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -1.23 0.05444 -1.561 0 0.273
144 LINC00861 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320b;hsa-miR-590-5p;hsa-miR-92a-3p 11 TGFBR2 Sponge network -1.254 0.02528 -1.561 0 0.269
145

TPTEP1

 hsa-miR-107;hsa-miR-146b-5p;hsa-miR-320b;hsa-miR-326;hsa-miR-330-5p;hsa-miR-342-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-877-5p 11 LEPR Sponge network -2.267 2.0E-5 -2.127 0 0.267
146

RP11-456K23.1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 14 TGFBR2 Sponge network -1.962 1.0E-5 -1.561 0 0.266
147

PART1

 hsa-miR-125a-3p;hsa-miR-146b-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-342-3p;hsa-miR-590-3p 10 KIT Sponge network -3.06 7.0E-5 -2.522 0 0.264
148

AF131217.1

 hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-26b-5p;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-34a-5p;hsa-miR-34c-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-590-3p 11 PDGFRA Sponge network -5.31 0 -2.376 0 0.264
149

LINC00865

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320b 10 TGFBR2 Sponge network -2.379 0 -1.561 0 0.262
150

TPTEP1

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p;hsa-miR-93-5p 14 TGFBR2 Sponge network -2.267 2.0E-5 -1.561 0 0.256
151

RP11-81H14.2

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-320a;hsa-miR-320b 10 TGFBR2 Sponge network -2.322 0.00014 -1.561 0 0.254
152

RP11-356J5.12

 hsa-miR-106a-5p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-92a-3p 15 TGFBR2 Sponge network -2.015 0 -1.561 0 0.251

Quest ID: ea1f28cba4c4d8c8ed27fb0d737ae38d